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  1 
Summary	  
 
Src proteins are non-receptor tyrosine kinases, which are known to play crucial roles in 
regulating cell proliferation and differentiation. They localize at the cytoplasmic face of 
the plasma membrane mediated by a dual lipid modification of their N-terminal SH4 
domains. Appreciable amounts of Src kinases are also found in intracellular 
compartments such as late endosomes, lysosomes and the Golgi apparatus. The lipid 
modifications of SH4 domains are both necessary and sufficient to mediate targeting of 
Src kinases to the inner leaflet of plasma membranes. However, the underlying 
mechanisms by which SH4-domain-containing proteins are transported to the plasma 
membrane are poorly understood. A genome-wide analysis to identify factors involved in 
SH4-domain-dependent protein targeting was carried out in a previous study of our 
laboratory by using an automated microscopy platform. We were able to identify proteins 
involved in lipid metabolism, intracellular transport and also cellular signaling processes. 
The goal of the current study was to validate and functionally characterize a subset of 
theses gene products. We were able to show that β-COP, a component of the heptameric 
coatomer complex, plays an important role in SH4-dependent protein transport. Likewise, 
we demonstrated a requirement for protein kinase C activity in correct targeting of SH4 
proteins to the plasma membrane. Further, the findings on mevalonate pyrophosphate 
decarboxylase (MVD) corroborate the role of cholesterol-dependent membrane 
microdomains in the plasma-membrane targeting of SH4 proteins. Finally, we challenged 
the hypothesis that nedd8-activating enzyme 1 (NAE1) or a functional neddylation 
pathway is required for correct targeting of SH4-proteins. Employing both RNA 
interference and dominant negative constructs of components involved in the neddylation 
pathway as well as a pharmacological inhibitor of NAE1, we were able to confirm a role 
of NAE1 in the proper intracellular targeting of SH4-YES; however, a functional 
neddylation pathway is not essential for this process. Hence, NAE1 may have a distinct 
function other than neddylation in the transport of SH4 proteins. These findings pave the 
way for future investigations on the underlying molecular mechanism for the targeting of 
SH4-domain containing proteins to the inner leaflet of the plasma membrane. 
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  2 
Zusammenfassung	  
 
 
Src Kinasen spielen eine zentrale Rolle in intrazellulären Signaltransduktionsprozessen, 
und sind so an verschiedenen zellulären Prozessen, wie Zellproliferation und -
differenzierung, beteiligt. Dabei ist ihre subzelluläre Lokalisierung für die funktionelle 
Interaktion mit anderen Proteinen von zentraler Bedeutung. Die stabile Assoziation mit 
Membranen wird durch eine N-terminale SH4-Domäne vermittelt, die über eine duale 
Lipidmodifikation an der zytoplasmatischen Seite der Plasmamembran verankert ist. Die 
erste Modifikation ist dabei eine Myristoylierung, welche eine transiente Interaktion mit 
intrazellulären Membrankompartimenten vermittelt und die Voraussetzung für eine 
darauffolgende Palmitoylierung ist. Diese zweite Modifikation bewirkt nicht nur eine 
stabile Membranverankerung, sondern begünstigt auch eine Anreicherung von SH4-
domänenhaltigen Proteinen in cholesterinreichen Membranmikrodomänen. Diese 
Assoziation findet vermutlich schon auf der Ebene intrazellulärer Kompartimente, z.B. 
im Golgi-Apparat, statt und könnte für eine Sortierung zur Plasmamembran erforderlich 
sein. Der molekulare Mechanismus, der dem mikrodomänenabhängigen Transport von 
SH4-Proteinen vom Golgi-Apparat zur Plasmamembran zugrundeliegt ist jedoch 
nichtbekannt. In einer vorausgehenden Studie unseres Labors wurde eine genomweite 
Analyse durchgeführt um molekulare Komponenten zu ermitteln, die am SH4-
abhängigen Transport zur Plasmamembran beteiligt sind. Hierbei wurden unter anderem 
Proteine identifiziert, die an der Lipidhomeostase, im intrazellulären Transport und an 
zellulären Signaltransduktionswegen beteiligt sind. 
Ziel der vorliegenden Studie war es, die Rolle dieser Faktoren im intrazellulären 
Transport von acylierten Proteinen zu bestätigen und funktionell näher zu 
charakterisieren. Wir konnten zeigen, dass der heptamere Coatomer-Komplex, sowie die 
Aktivität der Proteinkinase C für eine erfolgreiche Sortierung von SH4-Proteinen zur 
Plasmamembran erforderlich ist. Darüber hinaus wurde eine potentielle Beteiligung von 
Membranmikrodomänen am SH4-abhängigen Transport durch die Beobachtung 
untermauert, dass Änderungen der zellulären Cholesterinmenge mit einer intrazellulären 
Anreicherung acylierter Proteine einhergehen. Abschließend untersuchten wir, ob Nedd8-
activating enzyme 1 (NAE1), eine Komponente des zellulären Neddylierungsweges, 
sowie eine funktionelle Neddylierung für den Transport von SH4-Proteinen zur 
Plasmamembran erforderlich sind. Mithilfe von RNA Interferenz und dominant-
negativen Mutanten von Komponenten des Neddylierungsweges, sowie eines 
spezifischen Inhibitors von NAE1 konnten wir bestätigen, dass NAE1 für eine 
erfolgreiche Sortierung der SH4-Domäne der Src Kinase Yes erforderlich ist. Eine 
funktionelle zelluläre Neddylierungsmachschinerie ist jedoch keine essentielle 
Voraussetzung für diesen Prozess. Diese Beobachtung deutet darauf hin, dass NAE1 eine 
weitere, bisher unbekannte Funktion in der Sortierung von Src Kinase besitzt, die 
unabhängig vom Prozess der Neddylierung ist. 
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1 Introduction	  
 
Cells are the fundamental units of life, building up all living organisms. The biological 
universe consists of two types of cells: 1) prokaryotic cells which consist of a single 
compartment surrounded by the plasma membrane and lack a defined nucleus. 2) 
eukaryotic cells containing a defined membrane-bound nucleus and internal membranes 
that enclose the organelles. These internal membranes further subdivide the cell into 
different compartments, which differ from each other in terms of such as acidity and 
protein compositions and also their functions. To maintain their diverse functions, cells 
need to enrich the proteins selectively in different compartments. The distribution of 
newly synthesized proteins is mediated by the biosynthetic/secretory pathway. Along the 
secretory pathway, the transport between different organelles is mediated by coated 
vesicles, which contain not only soluble and membrane-bound proteins but also lipids. 
For a long time proteins were considered as the key factor for trafficking events whereas 
lipid were regarded as a passive solvent. Introducing the lipid raft concept in 1997, it was 
postulated that the assemblies of cholesterol-sphingolipid-proteins so called lipid rafts are 
important for protein delivery to the cell surface in many cell types. Doubly acylated 
proteins like Src-family kinases with raft affinity are probably also transported in a lipid-
raft dependent way to the plasma membrane. So far, our knowledge remains poor with 
regards to the underlying molecular mechanism. 
 
1.1 PROTEIN	  SECRETION	  AND	  ENDOCYTOSIS	  
1.1.1 Classical	  protein	  secretion	  
Most eukaryotic secretory proteins travel through the highly specialized ER/Golgi system 
to reach the plasma membrane or the extracellular environment. The ER exists in two 
different forms; the rough ER and the smooth ER (Borgese et al., 1974; Jones and 
Fawcett, 1966). Rough ER contains membrane-bound ribosomes where proteins are 
synthesized and translocated into the ER. These proteins are destined for lysosomes, for 
export or for transport to the plasma membrane (Borgese et al., 1974; Jones and Fawcett, 
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1966; Rapoport, 1992). A signal sequence on the nascent protein directs ribosomes to the 
ER membrane when a protein is translated on ribosome with an ER signal sequence 
(Blobel and Dobberstein, 1975a; Blobel and Dobberstein, 1975b; Rapoport, 1992; Walter 
et al., 1984; Wei and Hendershot, 1996). The signal recognition particle (SRP) present in 
the cytosol binds to the ER signal sequence and the ribosome. Through this interaction, 
the polypeptide elongation is slowed down (Keenan et al., 2001). Following dissociation 
of SRP and SRP receptor the ribosome is transferred to the translocation channel 
(Gilmore et al., 1982; Gorlich et al., 1992), protein synthesis continues and the nascent 
polypeptide is threaded through the channel and into the lumen of the ER (Corsi and 
Schekman, 1996). During translocation the signal sequence is cleaved off by a signal 
peptidase and released from the translocation channel and then degraded to amino acids 
(Blobel and Dobberstein, 1975a; Blobel and Dobberstein, 1975b; Dalbey and Von 
Heijne, 1992). Within the ER, chaperones help the newly synthesized protein in reaching 
its proper folding (Wei and Hendershot, 1996). Further processing includes the building 
of disulfide bonds, N- and O-glycosylation, oligomerization, proteolytic cleavage and 
other post-translational modifications (Ma and Hendershot, 2004). Misfolded or 
misprocessed proteins may be retained in the ER and later transported to the cytosol for 
degradation by the proteasome (Nishikawa et al., 2005). Correctly folded polypeptides 
are package into vesicles and transported to the Golgi, an organelle consist of cis-, 
medial- and trans-cisternae (Glick, 2000). Proteins enter the Golgi at the cis compartment 
and exit at the trans compartment. After proteins that arrive in the trans-Golgi network, 
they are transported to the plasma membrane in vesicles and can be released into the 
extracellular space.  
Concerning the intra-Golgi transport, two models exist: the first model “cisternal 
maturation” proposes that cargo remains in a given compartment and different enzymes 
arrive there to convert a cis cisterna into a medial one, a medial cisterna into a trans 
cisterna (Mellman and Simons, 1992; Mironov et al., 2005). Alternatively, the second 
model proposes that the cargo moves from one Golgi compartment to the next, 
encountering different enzymes in each subsequent compartment until it reaches trans 
cisterna (Mellman and Simons, 1992; Warren and Malhotra, 1998). This second model 
could use vesicles to transport cargo from one compartment to the next.  
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The COPII (coat containing complex II) machinery mediates cargo acquisition and is 
responsible for anterograde transport from the ER to the Golgi system (Barlowe, 1998; 
Lee et al., 2004; Rothman and Orci, 1992; Rothman and Warren, 1994). Small GTPase 
secretion-associated and Ras-related protein 1 (Sar1) initiates the recruitment of 
components and also the vesicle formation of COPII (Barlowe, 1998). Sar1-GTP recruits 
two cytosolic complexes the Sec23-Sec24 heterodimer and this complex interacts with 
cargo proteins via specific sorting signals (Matsuoka et al., 1998). This complex then 
recruits the Sec13-31 heterotetramer leading to polymerization and membrane 
deformation to form a COPII vesicle (Schekman and Orci, 1996). The exact nature of the 
interaction between Sec13-31 and Sec 23-24 is not known, however, Sec13-31 is 
probably providing a structural scaffold to crosslink Sec23-24 complexes, forming a coat 
lattice that propagates membrane curvature (Lee et al., 2004). After budding, the COPII 
vesicle sheds its coat, allowing its membrane to interact directly with the target 
membrane (Barlowe, 1998). 
In addition to COPII-coated-vesicles, COPI (coat containing complex I) coated vesicles 
handle the retrograde transport from Golgi back to the ER and as well as both 
anterograde and retrograde transport within the Golgi stacks (Cosson and Letourneur, 
1994; Letourneur et al., 1994; Nickel et al., 2002; Orci et al., 1997; Sonnichsen et al., 
1996). COPI coat assembly is initiated by GDP-GTP exchange onto the small GTPase 
ADP-ribosylation factor 1 (Arf1) (Peyroche et al., 1996). Membrane-bound Arf1 recruits 
coatomer complex, which is consistent of seven subunits: the α/β´/ε complex and the 
β/γ/δ/ζ complex to the p24 family at the membrane (Bonifacino, 2004; Pavel et al., 1998). 
After the formation of a COPI-coated vesicle, the coat must be shed to allow for vesicle 
fusion with the target membrane (Beck et al., 2009). The uncoating step depends on GTP 
hydrolysis by Arf1, catalyzed by Arf1 GTPase-activating proteins (ArfGAPs) (Tanigawa 
et al., 1993). Membrane curvature might facilitate the recruitment of ArfGAPs and 
subsequent dissociation from the membrane (Goldberg, 1998; Goldberg, 1999). Brefeldin 
A, a fungal toxin which stabilizes the Arf in GDP-bound state and inhibits the 
recruitment of COPI on the Golgi membrane and further blocks the classical secretory 
pathway (Kirchhausen, 2000; Mossessova et al., 2003; Robineau et al., 2000; Schmid, 
1997; Zhao et al., 1999). 
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Following vesicle formation the coat is released, SNARES (Soluble N-ethylamaleimide 
sensitive factor attachment protein receptor) (Bock et al., 2001; Clague, 1999; Rothman 
and Warren, 1994; Sollner and Rothman, 1996; Whyte and Munro, 2002) together with 
Rab family of GTPase and tethering factors ensure vesicle fusion with the target 
organelle (Novick and Zerial, 1997; Schimmoller et al., 1998b; Zerial and McBride, 
2001b; Zhao et al., 1999). Cognate v- and t-SNAREs recognize and form a coiled-coil 
trans-SNARE complex that brings the membranes close and drives the fusion process 
(Hanson et al., 1997; Rothman and Warren, 1994; Sollner et al., 1993; Sollner and 
Rothman, 1996). Following the fusion event, the cis-SNARE complex is disassembled by 
the recruitment through SNAPs (soluble NSF attachment protein) of the ATPase NSF (N-
thylmaleimide-sensitive fusion protein), which disassembles the SNAREpin and primes 
the membrane for another fusion event (Malsam et al., 2008; Zhao et al., 2007).  
TGN acts as the main sorting station of proteins and lipids. Sophisticated sorting 
machinery mediates cargo delivery to the plasma membrane, endosomal compartments 
and specialized compartments in diverse cell types. Clathrin-coated vesicles mediate the 
transport between the TGN and endosomes (Le Borgne and Hoflack, 1998a; Le Borgne 
and Hoflack, 1998b). Transport to the plasma membrane is mediated by the formation of 
large pleiomorphic carriers (LPCs) that is microtubules-dependent for the transport to 
their final destination (De Matteis and Luini, 2008; Luini et al., 2005). Apart from post-
translational modifications like glycosylation, the affinity of proteins to microdomains 
has an impact on sorting to the apical plasma membrane (Paladino et al., 2004; Schuck 
and Simons, 2004; Simons and van Meer, 1988). Sorting and transport machinery 
components and membrane material from the endosomal system and PM are recycled 
back to the TGN (De Matteis and Luini, 2008).  
1.1.2 Endocytosis	  
Endocytic membrane traffic in mammalian cells has an important role in recycling 
membrane components, ligands and molecules to various intracellular destinations. There 
are several ways for internalizing molecules from the cell surface. Receptor-mediated 
endocytosis involving the internalization of receptors and their ligands by clathrin-coated 
pits is most well studied and is characterized by high selectivity served by specific 
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trafficking motifs. Tyrosine-based motif, dileucine-based motif, NPXY and mono-/multi-
ubiquitination have been shown to direct clathrin-dependent endocytosis (Mousavi et al., 
2004). Adaptor proteins (AP) recognize both, these motifs and clathrin, bring them 
together, and initiate the creation of clathrin coat pits. AP-2 has been found to associate 
with tyrosine-based and di-leucine-based motifs, as well as with NPXY motifs. Adaptor 
proteins like epsin and EGFR pathway substrate clone 15 (Eps15) have been shown to 
bind to the ubiquitin moiety of cargo proteins. Clathrin-coated pits are dispatched and, 
upon fission mediated by GTPase dynamin, form clathrin-coated vesicles (Conner and 
Schmid, 2003). Subsequently, they undergo homotypic fusion and further fuse with 
sorting endosomes. From sorting endosomes, the cargo protein can follow two distinct 
routes: either to be recycled back to the plasma membrane directly or indirectly through 
recycling endosomes and/or TGN; or to enter the degradation pathway leading to 
lysosomes as a final destination (Maxfield and McGraw, 2004). Endosomal recycling is 
controlled by small Rab GTPases that act as molecular switches mediating trafficking 
between the various endosomal compartments. Rab4, Rab5 and Rab7 as well as Rab11 
have been localized to single endosomes where they segregate to distinct regions of the 
membrane and then define specific functional membrane domains (Sonnichsen et al., 
2000). More specifically, Rab4 seems to have a role in recycling membrane from the 
sorting endosomes, which perhaps includes direct recycling to the plasma membrane. 
Rab5 mediates the homotypic fusion between endocytic vesicles and the fusion between 
endocytic vesicles and sorting endosomes. Rab11 plays a role in recycling via recycling 
endosomes. Rab7 takes part in the pathway leading to late endosomes (Schimmoller et 
al., 1998a; Somsel Rodman and Wandinger-Ness, 2000; Zerial and McBride, 2001a).  
 
1.2 ACYLATION	  AND	  THEIR	  EFFECTS	  ON	  PROTEIN	  TARGETING	  
 
1.2.1 Acylation	  
1.2.1.1 N-­‐Myristoylation	  
N-myristoylation describes the addition of myristate (C14:0) to a N-terminal glycine 
residue, which happens cotranslationally while the nascent polypeptide chain is still 
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attaching the ribosome (Deichaite et al., 1988). The consensus sequence for N-myristoyl 
transferase (NMT) protein substrate is: (MGXXXS/T). The initial methionine is cleaved 
cotranslationally by methionine amino-peptidase and myristate is linked to gly2 via an 
amide bond. Many N-myristoylated proteins are membrane associated and can be found 
either at the plasma membrane or at intracellular membranes in eukaryotic cells. A 
mutation of Gly2 to Ala prevents myristoylation and inhibits membrane binding showing 
the absolute requirement for Gly at the N-terminus. However myristoylation alone is in 
most cases not sufficient for a stable membrane binding (Deichaite et al., 1988). 
According to the two-signal model for membrane binding of myristoylated proteins, a 
second signal for membrane binding, either a polybasic cluster of amino acids or a 
palmitate moiety, is required (Figure 1) (Resh, 1994). For the first model ‘myristate plus 
basic’, myristate inserts hydrophobically into the lipid bilayer and basic amino acids 
interact electrostatically with the headgroups of acidic phospholipids. This mechanism 
mediates stable membrane association of the non-receptor tyrosine kinase Src (Silverman 
and Resh, 1992). With an exception of Src itself, the stable membrane association of the 
other Src family kinases are mediated by a `myristate + palmitate´ signal (Resh, 1994).  
 
 
Figure 1 The two-signal model for membrane binding of myristoylated proteins. Membrane anchoring 
of myrisotylate proteins is stabilized by second membrane-binding signal, e.g. electrostatic interactions 
(myristate + basic) or a second acylation (myristate + palmitate) as well as interaction with membrane-
bound proteins (myristate/palmitate + protein:protein interaction) (from Resh, 1990).  
 
Since myristoylation alone is not sufficient for a stable membrane binding, myristoylation 
provides the opportunity of reversible membrane attachment. The MARCKS protein is a 
  Introduction 
    
  9 
protein kinase C (PKC) substrate and its membrane binding is regulated by a myristoyl 
electrostatic switch (McLaughlin and Aderem, 1995). Phosphorylation of MARCKS by 
PKC results in additional negative charges into the positively charged region. This leads 
to the reduction of the electrostatic interactions with acidic phospholipids and results in 
dissociation of MARCKS from the membrane and into the cytosol (Resh, 1999). Another 
potential example for a myristoyl-electrostatic switch is Src. The myristoylated SH4 
domain of Src contains phosphorylation sites by PKC and PKA. Phosphorylation of 
either site reduces the partitioning of Src onto lipid bilayers. However, translocation of 
Src from the membrane to the cytosol upon phosphorylation has not been consistently 
demonstrated (Murray et al., 1998; Resh, 1994; Walker et al., 1993). 
 
1.2.1.2 S-­‐Palmitoylation	  
S-palmitoylation describes the reversible attachment of palmitate (C16:0) to cysteine 
residues via a labile thioester bond. Protein palmitoylation has been shown to have a role 
in protein-membrane interactions, protein trafficking and enzyme activity. However, the 
underlying molecular machinery for reversible palmitoylation of proteins is not well 
known so far. Compared to N-myristoylation no strict consensus sequence is needed for 
palmitoylation, however, palmitoylated cysteine residues share some characteristics like 
a) they are close to myristoylation or prenylation sites b) they are frequently located in 
cytoplasmic regions flanking transmembrane domains (Salaun et al., 2010). Studies from 
yeast showed that some palmitoylated yeast proteins display a marked dependence on a 
specific DHHC (aspartate-histidine-histidine-cysteine) protein. However those studies 
also reveal that some DDHC proteins have overlapping substrate specificities which is in 
accordance with studies in mammalian systems showing that specific substrates can be 
palmitoylated by more than one DHHC protein (Fang et al., 2006; Fukata et al., 2004; 
Greaves et al., 2010; Shmueli et al., 2010; Tsutsumi et al., 2009). There are about 23 
putative S-palmitoyl transfereases in mammals. The large number of these DHHC 
proteins coupled with their localization to distinct membrane compartments (Ohno et al., 
2006) suggests that the palmitoylation machinery is a highly regulated and coordinated 
system (Salaun et al., 2010). 
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The question whether palmitoylation of newly synthesized peripheral proteins is a Golgi-
specific event is largely discussed. If it is so, specific palmitoylation at the Golgi might 
be an important prerequisite for the targeting to the plasma membrane. Recent studies 
took advantage of microinjection of semisynthetic N-Ras to study real-time 
spatiotemporal dynamics of palmitoylation (Rocks et al., 2010; Rocks et al., 2005). 
Immediately after microinjection, farnesylated N-Ras displayed a dispersed localization 
and followed by a rapid enrichment of the Cy3-labeled construct, which became apparent 
at the Golgi with plasma membrane staining visible at later time points (Rocks et al., 
2010). The simplest explanation is that palmitoylation of the farnesylated N-Ras occurs at 
the Golgi, leading to accumulation at this compartment and further to the plasma 
membrane by anterograde transport (Rocks et al., 2010). Further, it was shown by using 
low temperature to block vesicular transport along the secretory pathway, Fyn, TC10, R-
Ras and RhoB as well as Rap2C all displayed colocalization with a Golgi marker (Rocks 
et al., 2010). These observations imply that the Golgi may be a specialized reaction 
center for the palmitoylation of all newly synthesized peripheral proteins (Salaun et al., 
2010). Rocks et al. (2010) argued against DHHC substrate specificity and suggested there 
was also not an essential DHHC recognition domain in the remainder of the Ras protein, 
meaning the major requirement for palmitoylation was a suitable cysteine residue in close 
membrane proximity. However, this idea is not consistent with previous studies on the 
feature of DHHC proteins and substrate proteins that contribute to the specificity of 
interaction (Greaves et al., 2010; Greaves et al., 2009a; Huang et al., 2009; Nadolski and 
Linder, 2009). Indeed, the depletion of a single DHHC protein ERF2 affected the 
palmitoylation of yeast Ras (Bartels et al., 1999; Roth et al., 2006). This inconsistency 
still needs to be further investigated.  
 
Function of Palmitoylation 
Palmitoylation often couples with other lipid modification to regulate membrane 
associations of soluble proteins. N-myristoylation or prenylation provides a degree of 
hydrophobicity leading to a transient membrane interaction due to single lipid 
modifications (Shahinian and Silvius, 1995). An additional palmitoylation, promotes and 
stabilizes membrane attachment (Shahinian and Silvius, 1995). Thus, at cellular level, the 
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access to membrane bound DHHC proteins is first facilitated by myristoylation or 
prenylation and in the following palmitoylation stabilizes membrane binding (Figure 2). 
 
 
Figure 2 Regulation of membrane binding and trafficking of peripheral proteins by palmitoylation. 
(A) Proteins modified with single lipid groups (prenylation or N-myristoylation; green circles) have a weak 
membrane affinity that allows transient membrane interaction. Palmitoylation by membrane-bound DHHC 
proteins promotes stable membrane association by kinetic trapping. (B) Palmitoylation leads to a dramatic 
increase in membrane affinity by kinetic trapping. This increased membrane residency facilitates entry of 
palmitoylated proteins (red circles) into transport vesicles that deliver it to the plasma membrane. It is 
possible that palmitoylation also serves to move palmitoylated proteins into cholesterol-rich domains from 
which Golgi exit vesicles are formed (Salaun et al., 2010).  
 
Therefore, a main function of palmitoylation is to stabilize the membrane attachment of 
soluble proteins, including farnesylated Ras and myristoylated Gα (Hancock et al., 1990; 
Linder et al., 1993; Parenti et al., 1993). Some soluble proteins are solely S-
palmitoylated, and these proteins may use a weak membrane affinity for the transient 
membrane interaction before palmitoylation (Greaves et al., 2009a; Greaves et al., 2008; 
van Zanten et al., 2009). 
Another central function of palmitoylation is the regulation of protein targeting to many 
distinct intracellular compartments (Greaves et al., 2009b; Linder and Deschenes, 2007), 
such as regulating of protein sorting on retention or anterograde transport of proteins at 
the ER-Golgi as well as protein cycling within the endosomal/lysosomal system (Greaves 
et al., 2009b; Linder and Deschenes, 2007). The underlying mechanism of palmitoylation 
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on protein sorting can be divided in two aspects. First, for some soluble proteins, 
palmitoylation may act as a passive sorting signal that provides an essential membrane 
anchor and in this way allow other protein domains to regulate further trafficking (Salaun 
et al., 2010). Second, palmitoylation may achieve active effects on protein sorting by 
driving partitioning of proteins into lipid-rafts (Levental et al., 2010b), or changing the 
orientation of proteins and protein-protein interactions (Hayashi et al., 2005; Lin et al., 
2009) or regulating ubiquitination and thus modulating ubiquitination-dependent protein 
sorting (Valdez-Taubas and Pelham, 2005). Previous studies showed that the affinity to 
lipid rafts might facilitate the targeting of palmitoylated proteins from the Golgi to 
plasma membrane (Levental et al., 2010a; Melkonian et al., 1999). Further, it was 
proposed that lipid rafts might act as platforms for vesicle budding from the Golgi 
(Patterson et al., 2008).  
  
Depalmitoylation 
In contrast to the information available on palmitoylation, our current understanding of 
depalmitoylation is poor. Previous analysis of an N-Ras protein in which the palmitoyl 
group was attached by a noncleavable thioether linkage revealed a dispersed intracellular 
localization without Golgi enrichment (Rocks et al., 2005). It was suggested that this 
localization reflect a requirement for active regulation of palmitoylation/depalmitoylation 
cycling to achieve the correct localization of Ras. In comparison to the noncleavable 
thioether linkage, the palmitoylated protein with a cleavable thioester bond was therefore 
not expected to display any initial membrane targeting specificity. Despite this, the 
construct rapidly accumulated at the Golgi. This accumulation was suggested to follow 
on from binding of the farnesylated/palmitoylated protein to any membrane, 
depalmitoylation, and subsequent repalmitoylation at the Golgi. There were two main 
interpretations made from this behavior of farnesylated and palmitoylated N-Ras: 1) 
depalmitoylation must be very rapid to account for the speed of Golgi accumulation and 
2) depalmitoylation must occur throughout the cell because if it was confined to a 
specific location, association of the farnesylated and palmitoylated protein with some 
membranes would be irreversible (Salaun et al., 2010). Meanwhile, a cycle of 
palmitoylation/depalmitoylation of H-Ras has been extensively analyzed (Ahearn et al., 
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2011; Goodwin et al., 2005; Rocks et al., 2005; Roy et al., 2005). Acyl protein 
thioesterase 1 (APT1) is bona fide candidate depalmitoylating enzyme shown to mediate 
palmitate removal from H-Ras in vitro (Duncan and Gilman, 1998; Yeh et al., 1999). 
Despite APT1 being identified many years ago, its physiological importance of this 
protein as a thioesterase is not clear (Salaun et al., 2010). The recent description of a 
novel APT1 inhibitor (palmostatin B) provided an important tool to more characterize the 
function of APT1 in cellular palmitoylation dynamics (Dekker et al., 2010). Initial studies 
with palmostatin B suggests that it promotes a moderate increase in Ras palmitoylation 
and thus disrupts the intracellular localization of Ras (Salaun et al., 2010). A recent study 
showed that the prolyl isomerase (PI) FKBP12 binds to H-Ras in a palmitoylation-
dependent fashion and promotes depalmitoylation in a dependent manner of cis-trans 
isomerization of a peptidyl-prolyl bond in proximity to the palmitoylated cysteines 
(Ahearn et al., 2011).  
 
1.2.2 Lipid	  rafts	  
The lipid rafts concept  
The lipid raft concept was introduced in 1997 by Simons and Ikonen. The term “lipid 
raft” was assigned to describe assemblies that were mainly generated by lipid-lipid 
interactions that lead to a phase separation of liquid- ordered (lo) and liquid-disordered 
(ld) phases within the membrane (Simons and Ikonen, 1997). In this work they postulated 
lipid rafts could function in membrane trafficking and signaling (Simons and Ikonen, 
1997). In the liquid-ordered phase, sphingolipids associate laterally with one another 
probably via weak interactions between the carbohydrate heads of the 
glycosphingolipids. The saturated hydrocarbon chains in cell sphingolipids allows for 
cholesterol to be tightly intercalated filling voids created by interdigitating fatty acid 
chains (Figure 3). The inner leaflet is probably rich in phospholipids with saturated fatty 
acids and cholesterol; however, its characterization is still poorly understood.  
A key issue ten years ago was the methodology used for the definition of a raft 
component. Raft constituents were defined as the insoluble fraction or detergent-resistant 
membrane (DRM) remaining after non-ionic detergent solubilisation at 4°C. This 
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criterion was often combined with the use of methyl-β-cyclodextrin to deplete cholesterol 
from cell membranes. This raised questions such as to whether rafts were a real 
physiological phenomenon (Munro, 2003; Shaw, 2006) because detergent solubilisation 
is an inherently artificial method giving different results depending on the concentration 
and type of detergent, duration of extraction and temperature (Lingwood and Simons, 
2007; Simons and Gerl, 2010). Also cyclodextrin treatment led to side effects such as 
lateral protein immobilization (Kenworthy, 2008). There were claims that the lipid raft 
was at a technical impasse because a physical tool to study biological membrane was still 
lacking (Jacobson et al., 2007).  
 
 
Figure 3 Model membrane containing lipid rafts. Cholesterol is important component of Io phase 
membrane and fill interstitial spaces between lipids. Lipid rafts contains cholesterol and sphingolipid and 
specific proteins like GPI-anchored proteins in the outer leaflet and Src-kinase partition into the inner 
leaflet (Maxfield and Tabas, 2005).  
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So far the size of rafts and their lifetime has continued to be investigated, and the size 
seems to vary depending on the method employed to measure them while particularly the 
lifetime remains controversial (Jacobson et al., 2007). Currently, lipid rafts are viewed as 
dynamic nanoscale assemblies enriched in sphingolipid, cholesterol and GPI-anchored 
proteins (Hancock, 2006). This nanometer-size scale was later supported by viscous drag 
measures of antibody-bound raft proteins and electron microscopic observation of labeled 
raft antigens (Pralle et al., 2000). Novel microscopy techniques provided more data 
favoring the existence of nanoscale rafts in resting and activated cells (van Zanten et al., 
2009). Though different techniques are yielding a range of values for different molecular 
constituents in different cell types, all data point to the existence of small, dynamic and 
selective cholesterol-dependent heterogeneity in the plasma membranes of living cells 
(Lingwood and Simons, 2010).  
 
Lipid rafts in membrane trafficking 
Since proteins associate with lipid rafts during apical transport, rafts could act as apical 
sorting platform (Simons and Ikonen, 1997). In polarized cells the sorting of many apical 
proteins may be governed by lipid-lipid and lipid-protein interactions instead of direct 
protein-protein interactions with apical sorting determinants in membrane anchors or 
extracellular domains that have not been identified (Schuck and Simons, 2004). Recent 
work has revealed the ability of individual rafts to cluster selectively into large domains 
and this finding led to a more comprehensive model for the role of lipid rafts in polarized 
sorting (Figure 4). Though the size and stability of rafts is controversial, there are 
indications that individual rafts can be induced to form large, stable clusters (Kusumi et 
al., 2004; Simons and Vaz, 2004). This clustering can be artificially initiated by antibody 
crosslinking but also occurs naturally for example when interactions between T-cell 
receptor and peptides bound to major histocompatibility complexes (MHC) on antigen-
presenting cells trigger the clustering of lipid rafts during the formation of immunological 
synapses (Harder et al., 1998). As a consequence of lipid raft clustering, the affinity of 
transmembrane proteins to lipid rafts is further increased, whereas non-raft components 
are excluded (Schuck and Simons, 2004). Remarkably, antibody crosslinking of PLAP 
leads to clustering of the doubly acylated raft protein Fyn that resides on the inner leaflet 
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of the membrane. Thus, the crosslinking of one raft protein moves whole lipid rafts 
together in both membrane leaflets (Harder et al., 1998; Prior et al., 2003). The 
spontaneous curvature of lipid raft that results by lipid asymmetry between the inner and 
outer membrane leaflets could play a role in controlling the budding process (Huttner and 
Zimmerberg, 2001; Schuck and Simons, 2004). Therefore, raft clustering is a mechanism 
for the selective recruitment of proteins and lipids that have an affinity for liquid-ordered 
domains and meanwhile the efficient exclusion of non-raft proteins (Schuck and Simons, 
2004).  
 
Figure 4 Raft clustering and domain-induced budding. A: GPI-anchored protein (gold) exclusively in 
rafts, a doubly acylated protein (red) mainly in rafts, a transmembrane protein (green) mainly out of rafts.  
B: When clustering is induced e.g. by the binding of annexin type (blue) to the cytoplasmic face of rafts, 
GPI-anchored and acylated protein partition into clustered rafts while weakly raft-associated 
transmembrane protein is driven into rafts by crosslinking a divalent interaction partner, e.g. a lectin 
(black). C: Growth of the clustered raft domain beyond size induces budding. D: Fission occurred at the 
domain boundaries (Schuck and Simons, 2004). 
 
The yeast raft lipids, which are the cholesterol homologue ergosterol and sphingolipids, 
were recently shown to regulate the transport of detergent-resistant cargo to the plasma 
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membrane (Simons and Gerl, 2010). Immunoisolation and mass spectrometry analysis of 
TGN-derived vesicles showed that ergosterol and yeast sphingolipid were selectively 
enriched and the most abundant lipids in the transport vesicles (Klemm et al., 2009; 
Schuck and Simons, 2004). These were the first data giving direct experimental support 
to the hypothesis that raft cargo proteins are delivered from Golgi to the cell surface in a 
lipid raft carrier (Simons and Gerl, 2010). Bringing together apical sorting motifs mediate 
partitioning into newly formed raft clusters at the level of the Golgi which further 
promote formation of transport carriers by domain-induced budding (Schuck and Simons, 
2004). 
 
1.3 INTRACELLULAR	  TRANSPORT	  OF	  ACYLATED	  SH4	  PROTEINS	  
 
1.3.1 Src	  Family	  Kinases	  
Src-family kinases, a family of non-receptor tyrosine kinases, includes at least eight 
highly homologous proteins: c-Src, Lyn, Fyn, c-Yes, c-Fgr, Hck, Lck and Blk (Thomas 
and Brugge, 1997). Src-family kinases are known to play roles in regulating cell 
proliferation and differentiation (Thomas and Brugge, 1997). Src, Lyn, Yes and Fyn are 
widely expressed in a variety of cell types, whereas Blk, Hck, Fgr and Lck are found 
primarily in hematopoietic cells (Bolen and Brugge, 1997; Thomas and Brugge, 1997).  
 
 
Figure 5 Schematic representation of Src domain structure. Src is composed of an N-terminal 
myristoylated SH4-domain, the unique region followed by SH3 and SH2 domain, a linker region (L) and a 
catalytic kinase domain that contains Y419 and a C-terminal regulatory domain (R) that contains Tyr530. 
 
Src-family tyrosine kinases are composed of: (1) an N-terminal Src homology SH4 
domain conferring membrane binding via one or several acylations (2) a poorly 
conserved domain, (3) an SH3 domain binding specific proline-rich sequences thus 
SH4 
     SH3 SH2  Tyr	  Kinase Unique 
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 R 
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mediating protein-protein interactions, (4) an SH2 domain, which can bind to specific 
sites of tyrosine phosphorylation, (5) an SH1 tyrosine kinase catalytic domain which 
contains an autophosphorylation site and mediates enzymatic activity (6) a C-terminal 
negative regulatory tail for autoinhibition of the kinase activity (Brown and Cooper, 
1996) (Figure 5). It is generally thought that SFKs are predominantly located at the 
cytoplasmic face of plasma membrane by lipid modifications (Resh, 1994), however, 
appreciable fractions are also found at other intracellular locations, such as endosomes, 
secretory granules or phagosomes and the Golgi complex (Brown and Cooper, 1996; 
Kaplan et al., 1992; Kasahara et al., 2004; Mohn et al., 1995; Thomas and Brugge, 1997). 
Although distinct localizations of Src members have been implicated in their specific 
functions, the mechanism that underlies the targeting of SFKs to their specific locations 
remains to be elucidated.  
 
Intracellular trafficking of Src, Lyn, Yes and Fyn 
Early studies demonstrated that SFKs interact with membranes through their lipid 
acylation in the N-terminal SH4 domain (Blenis and Resh, 1993; Resh, 1993; Silverman 
et al., 1993). A recent study by Sato et al. (2009) showed that the differential trafficking 
of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain. 
They demonstrated that Src as a nonpalmitoylated Src is rapidly exchanged between the 
plasma membrane and late endosomes/lysosomes. Lyn and Yes as monopalmitoylated 
SFKs are transported via the Golgi region along the secretory pathway, whereas a large 
fractions of Fyn, a dually palmitoylated SFK is directly targeted to the plasma membrane.  
Src is one of two Src family kinases that are only myristoylated but not palmitoylated 
(Figure 6). A basic cluster of amino acids provides the second signal for membrane 
binding (Koegl et al., 1994; Resh, 1994; Shenoy-Scaria et al., 1994). Src is rapidly 
SRC    M G S N K S K P K D A S Q R R R S L 
FYN    M G C V Q C K D K E A T K L T E E R 
YES    M G C I K S K E N K S P A I K Y R P 
LYN    M G C I K S K G K D S L S D D G VD 
Figure 6 Primary sequences of the N-terminal 18 amino acids of SH4 domain of SFKs. 
Myristoylated glycines are highlighted in blue and palmitoylated cysteines are highlighted in green. 
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exchanged between late endosomes or lysosomes and the plasma membrane, possibly 
through its cytosolic release (Kasahara et al., 2004). Src-containing endosomes are RhoB-
positive at the perinuclear-recycling compartment, which participates in actin-dependent 
transport of Src to the plasma membrane (Sandilands et al., 2007).  
 
Lyn and Yes are myristoylated and monopalmitoylated SFKs (Figure 6). Newly 
synthesized Lyn and Yes initially are at the cytoplasmic face the Golgi system, where 
palmitoylation probably happens. This provides entry into the secretory pathway to the 
plasma membrane (Kasahara et al., 2004). Lyn as a member of Src-family tyrosine 
kinases is widely expressed and has an important role in signal transduction at the 
cytoplasmic face of the plasma membrane (Tsukita et al., 1991). Incorporation of one or 
more palmitate moieties is reported to facilitate localization of Yes and Fyn to lipid rafts 
(Shenoy-Scaria et al., 1994). The transport of Lyn and Yes to the plasma membrane is 
blocked by low temperatures (19°) and dominant-negative Rab 11, indicating export via 
the TGN (Sato et al., 2009). Recently it was shown that newly synthesized Lyn 
accumulates on Golgi membranes and later will be transported along the secretory 
pathway in a Lyn kinase domain dependent manner to the plasma membrane (Obata et 
al., 2010). Moreover, it was demonstrated that the C-lobe of the Lyn kinase domain 
associates with long-chain acyl-CoA synthetase 3 (ACSL3) when Lyn positions in an 
open conformation, thereby initiating export from the Golgi (Obata et al., 2010). Ikeda et 
al. (2009) showed that besides N-terminal acylation, the kinase domain but not kinase 
activity of Lyn is also required for the targeting of newly synthesized Lyn to the Golgi, 
especially to the caveolin pool of the Golgi. Lack of Lyn kinase domain induces 
accumulation of Lyn on caveolin-negative Golgi membranes and thus inhibits the 
transport pathway to the plasma membrane (Ikeda et al., 2009).  
 
After myristoylation and dual palmitoylation, newly synthesized Fyn is targeted directly 
to the plasma membrane (van't Hof and Resh, 1997). It was shown that Fyn interact with 
the plasma membranes 5 minutes after its biosynthesis and partition into membrane 
microdomains 10-20 minutes after membrane association (van't Hof and Resh, 1997). 
Further it was shown that palmitoylation of the SH4-domain of Fyn is sufficient to target 
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chimeric proteins to DRMs and plasma membrane (Wolven et al., 1997). The SH4 
domain of Fyn contains two cysteine at position 3 and 6; deletion of cysteine 6 did not 
constrain membrane targeting however resulted in the export via the secretory pathway 
similar to the export of monoplamitoylated SFKs Yes and Lyn (Sato et al., 2009). 
Moreover, Fyn C3S/C6S that is no longer palmitoylated, behaves much more like Src by 
colocalization with RhoB endosomes while wild type Lyn is found to localize with Rho 
D endosomes (Sandilands et al., 2007). Liang et al. (2004) showed that methylation of its 
N-terminal domain lysine 7 and/or 9 is required for the functionality of Fyn that is 
dependent on the previous acylation.  
 
 
Figure 7: Schematic model of three major pathways for SFK targeting to the plasma membrane. (i) 
c-Src as an example for only myristoylated but not palmitoylated SFKs. The cycling of c-Src between late 
endosome/lysosomes and the plasma membrane is shown. (ii) Lyn or c-YES as for myristoylated and 
monoplamitoylated SFKs. The secretory pathway of Lyn/c-YES from Golgi apparatus to the plasma 
membrane is depicted. (iii) FYN as myristoylated and dually palmitoylated SRKs target direct to the 
plasma membrane (Sato et al., 2009).  
 
1.3.2 Hydrophilic	  Acylated	  Surface	  Protein	  B	  (HASPB)	  
Hydrophilic Acylated Surface Proteins (HASPs) are members of Lm cDNA 16 gene 
family that encodes five genes located on a single choromosome in the Leishmania major 
genome. Gene B (HASPB) is a protein localizing to the surface of Leishmanina parasites 
only at infective stages (Pimenta et al., 1994). Deletion of the complete Lm cDNA locus 
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results in an increased sensitivity to complement-mediated lysis (McKean et al., 2001). 
HASPB is a predominantly hydrophilic molecule of 177 amino acids. Heterologous 
expression of HASPB in mammalian cells causes in externalization of the protein to the 
outer leaflet of the plasma membrane suggesting the underlying machinery required for 
export of HASPB is conserved among eukaryotes (Denny et al., 2000; Stegmayer et al., 
2005). Export to the extracellular leaflet of the mammalian plasma membrane functions 
via direct translocation by an unknown mechanism (Stegmayer et al., 2005). 
Overexpression of SH4-HASPB in Chinese hamster ovary (CHO) cells results in a 
formation of highly dynamic non-apoptotic blebs of the plasma membrane (Tournaviti et 
al., 2007).  
HASPB contains an N-terminal SH4 domain that undergoes dual acylation at glycine 2 
for myristoylation and cystein 5 for palmitoylation (Denny et al., 2000). The 18 amino 
acids of SH4 domain is sufficient to target a reporter molecule such as GFP to the cell 
surface of parasites and mammalian cells (Denny et al., 2000; Stegmayer et al., 2005; 
Tournaviti et al., 2009). It was shown that incubation with brefeldin A, a drug causing a 
collapse of Golgi into the ER in mammalian cells does not interfere with the localization 
of HASPB at the plasma membrane in CHO cells (Denny et al., 2000). Based on these 
observations HAPSB has been termed an unconventional secretory protein (Denny et al., 
2000). In accordance to these observations, HASPB does not contain a classical signal 
peptide and further it is not glycosylated, a modification that is cotranslational in the ER 
and continues in the Golgi (Denny et al., 2000). In addition, it was demonstrated that 
mutation of the glycine at position 2 results in abrogation of myristoylation and the 
subsequent palmitoylation and the intracellular translocation of HASPB mutant in both 
mammalian and parasitic cells (Denny et al., 2000). In contrast, mutation of the 
palmitoylation site results in accumulation of myristoylated HASPB at perinuclear 
membranes and its failure to partition into lipid rafts (Tournaviti et al., 2009), which 
seems to be the prerequisite for the targeting to the plasma membrane (Figure 8). Recent 
studies identified threonine 6 as a phosphorylation site of the SH4 domain of HASPB 
(SH4-HASPB) (Tournaviti et al., 2009). It was demonstrated that a threonine 6 to 
glutamate (T6E) exchange as a phosphorylation mimic resulted in a redistribution of 
SH4-HASPB from the plasma membrane to intracellular sites with a strong accumulation 
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in a perinuclear region (Tournaviti et al., 2009). In comparison, a threonine 6 to alanine 
(T6A) mutation did not disturb plasma membrane localization of SH4-HASPB 
(Tournaviti et al., 2009). The fact that both mutations (T6E and T6A) do not affect the 
partition of SH4-HASPB into DRMs indicates the regulation by a DRM-independent 
endocytic step (Tournaviti et al., 2009). Similar to the perinuclear accumulation of the 
phosphomimetic mutant, SH4-HASPB accumulates at perinuclear membranes when 
protein phosphatases PP1 and PP2A were downregulated by RNAi (Tournaviti et al., 
2009). It was suggested that Sh4 proteins cycle back and forth between the plasma 
membrane and perinuclear compartments a process that is controlled by a regulatory 
cycle of phosphorylation and dephosphorylation (Tournaviti et al., 2009). 
 
 
Figure 8 Schematic model of intracellular trafficking of acylated Src family kinases. SH4-domains 
interact with the ER/Golgi upon myristoylation where they are palmitoylated. Palmitoylated SH4-domains 
partition into microdomains and then are ready to be exported to the plasma membrane. A phosphorylation 
cycle regulates endocytosis and recycling without affecting microdomain association (modified from 
Nickel, 2005). 
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1.4 UBIQUITINATION	  RELATED	  POST-­‐TRANSLATIONAL	  PROTEIN	  
MODIFICATIONS	  
 
Ubiquitination is a prominent post-translational protein modification that regulates most 
cellular functions in eukaryotes (Glickman and Ciechanover, 2002; Haglund and Dikic, 
2005; Weissman, 2001). Since the discovery of ubiquitin in the mid-1970s, an entire 
family of small proteins related to ubiquitin has resulted in the distribution of so called 
ubiquitin-like proteins or UBLs. All structurally characterized UBLs share the ubiquitin 
or β-grasp fold, even when their primary sequences are not detectably similar (Kerscher 
et al., 2006). Ubiquitin (Ub) and ubiquitin-like proteins (UBLs) share similar enzymatic 
mechanisms for their conjugation onto target proteins (Figure 9). The first step into a 
conjugation pathway requires an ATP-dependent activation through the formation of an 
adenylate intermediate in the nucleotide-binding pocket of their cognate E1 (activating 
enzyme) (Ciechanover et al., 1981; Haas et al., 1982). After this, the activated Ub/UBLs 
is transferred onto the catalytic cystein of E1 to form a high-energy thioester intermediate 
(Huang et al., 2007). Further, thioesterified Ub/UBLs will be transferred from E1 to E2 
(the conjugating enzyme) catalytic cysteine with associated conformation changes, which 
requires a “fully loaded” E1 complex with two bound Ub/UBLs, one in adenylated form 
Ub/UBLs and the other linked via thioester bond Ub/UBLs (Huang et al., 2007). Finally, 
the Ub/UBLs is covalently transferred when a lysine side chain of the substrate is 
positioned in the way that it can destabilize the thioester linkage between Ub/UBLs and 
E2 and further promote the formation of a peptide bond. This step is usually assisted by 
E3s (ligases) that interact with protein substrates and activate E2 to facilitate this 
reaction.  
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Figure 9 The basic principles of the ubiquitin-conjugation pathway. Three types of enzymes: E1, E2 
and E3 participate in ubiquitination. E1 activates ubiquitin and E2 picks up the ubiquitin by transthiolation 
from E1 and conjugate it to substrates. E3 then ligates the ubiquitin to the substrates (Hochstrasser, 2009).  
 
1.4.1 Ubiquitination	  
Ubiquitin is a highly conserved protein of eight kD that is conserved among eukaryotes 
but absent from bacteria and archaea. Classically, the best understood function of 
ubiquitin is the targeting of proteins for degradation by the proteasome where ubiquitin is 
attached in the form of a polyubiquitin chain to the substrate that is then recognized by 
specific receptors within the proteasome or by adaptor proteins that subsequently bind the 
proteasome (Elsasser et al., 2002; Young et al., 1998). Generally, ubiquitination also 
remodels the surface of substrate proteins and thereby potentially affects properties such 
as stability and activity (Pickart and Fushman, 2004), drives interaction with other 
proteins and plays roles in subcellular localization of their substrate (Mukhopadhyay and 
Riezman, 2007). Diverse forms of Ub modifications exist: 1) Monoubiquitination is the 
attachment of a single Ub to a protein; 2) Multiubiquitintion occurs when several Lys 
residues of the target protein are tagged with single Ub molecules; 3) Polyubiquitination 
describes a single Ub chain where the c-terminus of ubiquitin is bound to the previous 
ubiquitin via an isopeptide bond with an ε-amino group of a lysine residue (Hochstrasser, 
2006). Monoubiquitination or multiubiquitination has been shown to be required for the 
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entry of certain cargo proteins into vesicles at the different stages of the 
secretory/endocytic pathway (Hicke, 2001) while polyubiquitination is mainly associated 
with proteasomal degradation although it certainly has a wide function (Pickart and 
Eddins, 2004). One of the nonproteasomal functions of ubiquitination was its implication 
in endocytosis in yeast (Hicke and Riezman, 1996; Kolling and Hollenberg, 1994), where 
monoubiquitination functions as an endocytic internalization signal (Terrell et al., 1998). 
However, this function is much less clear in mammalian cells. 
 
1.4.2 Neddylation	  
Neddylation is a post-translational protein modification that is closely related to 
ubiquitination. While ubiquitination regulates a myriad of processes in eukaryotic cells, 
there are only limited substrates for neddylation discovered to date. NEDD8, a UBL 
protein, was originally identified in the embryonic mouse brain (Kumar et al., 1992).  
Further it was found that NEDD8 is highly conserved in most eukaryotes where it is 
expressed in most tissues indicating an important function in eukaryotic cells (Carrabino 
et al., 2004; Hori et al., 1999; Kumar et al., 1992). Indeed neddylation is essential for the 
viability of most model organisms including Caenorhabditis elegans, Drosophila and 
mouse with the exception of S. cerevisiae (Lammer et al., 1998; Liakopoulos et al., 1998) 
and deregulated neddylation might be involved in some human diseases such as 
neurodegenerative disorders and cancers (Chairatvit and Ngamkitidechakul, 2007; Salon 
et al., 2007).  
Similar to ubiquitination, neddylation involves a three-step cascade (Figure 10). ATP-
dependent NEDD8 activation is initiated by the NEDD8 E1 enzyme NAE1-UBA3, which 
creates a high-energy intermediate (Huang et al., 2004a). This is transferred to the 
NEDD8 E2 conjugation enzyme UBC12 (Huang et al., 2007) and finally, the conjugation 
to a lysine residue of a target protein is mediated with help of NEDD8 E3 ligase, which 
then ensures specific conjugation to its substrates. The NEDD8 E1 activity is carried out 
by a heterodimer of NAE1 and UBA3, which are homologous to the amino- and C-
terminal domains of ubiquitin-activating enzyme, respectively (Liakopoulos et al., 1998; 
Osaka et al., 1998; Walden et al., 2003). The NAE1 binding site for UBA3 lies within 
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amino acid 443-479. Differently to ubiquitination, where ubiquitin can be transferred by 
multiple E2s, Ubc12 is the unique E2 for Neddylation (Liakopoulos et al., 1998). Indeed, 
despite of the high similarity between Ubiquitin and NEDD8, Ubc12 is exclusively 
loaded by NEDD8 and a covalent oxyester bond between the carboxyl-terminal glycine 
of NEDD8 and cysteine of UBC12 is formed (Leck et al., 2010). Protein neddylation is 
reversed by NEDD8 isopeptidases in a process known as deneddylation. Currently, the 
best-characterized NEDD8 isopeptidase is CSN5, a subunit of the COP9 signalsome 
(CSN), which deneddylates cullins (Schwechheimer, 2004; Wei and Deng, 2003). The 
CSN is conserved from yeast to humans (Schwechheimer, 2004; Wei and Deng, 2003) 
and essential for the viability in metazoans (Cope and Deshaies, 2003). 
 
 
Figure 10 Schematic depiction of neddylation pathway. NEDD8 is activated by UBA3-APPBP1 
(NAE1) heterodimer, further loaded onto the UBC12, conjugated to the substrate by E3 and recycled by an 
isopeptidase (from Rabut and Peter, 2008).  
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The first identified targets of NEDD8 were Cdc53 in S. cerevisiae (Liakopoulos et al., 
1998) and CUL4A in human cells (Osaka et al., 1998), both of which are cullin family 
proteins. Cullins function as a part of the catalytic core of cullin-RING ubiquitin ligases 
(CRLs) (Petroski and Deshaies, 2005), which recruits charged ubiquitin E2s into the 
complex and catalyzes the ubiquitination of cullin substrates (Seol et al., 1999). Up to 
date, it is still unclear how many other proteins are modified by NEDD8 despite several 
proteomic approaches (Jones et al., 2008; Norman and Shiekhattar, 2006; Xirodimas et 
al., 2008). These studies confirmed that cullins are abundant NEDD8 substrates, however 
failed to identify other previously characterized neddylated proteins except p53 (Li et al., 
2006). 
 
 
Figure 11 Examples of direct effects of neddylation. (A) Neddylation induces conformational changes. 
(B) Neddylation precludes association with certain partners or competes with other posttranslational 
modifications. (C) Neddylation provide a novel binding surface to recruit new partners (Rabut and Peter, 
2008). 
 
Neddylation of proteins modifies their three-dimensional surface and, hence, their 
biochemical properties (Rabut and Peter, 2008). The effects can be classified into three 
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categories which have subsequent consequences in subcellular localization or enzymatic 
activity (Figure 11) (Rabut and Peter, 2008). First, neddylation can induce 
conformational changes of its targets. Studies about cullins showed that the c-terminal 
domain of cullin forms a groove where Rbx1 is embedded and this conformation 
constrains the movement of Rbx1 and positions the E2 away from its ubiquitination 
substrates (Zheng et al., 2002). Neddylation of cullin induces a conformation switch in its 
C-terminal domain that frees the RING domain of Rbx1 thus allows it to adopt different 
orientations and to stimulate substrates of ubiquitination in vitro (Duda et al., 2008). As a 
second possibility, neddylation can preclude certain interactions (Rabut and Peter, 2008). 
Neddylation of cullin1 not only activates Rbx1 but also prevents it from binding to the 
cullin inhibitor CAND1 (Duda et al., 2008). Another example is that neddylation of 
EGFR can inhibit further ubiquitination since neddylation and ubiquitination modify 
overlapping lysines of EGFR (Oved et al., 2006). Finally, neddylation can stimulate the 
recruitment of NEDD8 interaction proteins. For example, neddylated EGFR likely 
provides a novel binding surface to recruit endocytic proteins such as Eps 14 or Hrs 
(Oved et al., 2006).  
 
The amyloid precursor protein (APPs, 695-770 amino acids) is a ubiquitous membrane 
protein and its increased processing is believed play a role in Alzheimer´s disease(Muller 
and Kins, 2002). APP is a cell surface protein with a large extracellular amino-terminal 
domain, a single transmembrane segment and a short cytoplasmic tail. The cleavage of 
APP by α- and β-secretase yields a secreted form of APP and a C-terminal fragment 
(C83), and alternative cleavage by the β-secretase produces the C-terminal fragment 
(C99) which is further cleaved by γ-secretases to generate the amyloid peptide Aβ and the 
APP intracellular domain (AICD) fragment (C50) (Gu et al., 2001; Kerr and Small, 
2005). In addition, APP was shown to be neddylated and functionally neddylation 
inhibits AICD-mediated transcriptional activation due to the inhibition of its interaction 
with the co-activator Fe65 and Tip60 (Lee et al., 2008). Further, it was proposed that the 
regulatory mechanisms by which AICD transcriptional activity might be regulated via 
covalent conjugation with NEDD8 (Lee et al., 2008). 
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1.5 AIM	  OF	  THIS	  STUDY	  
 
While it was known for nearly 20 years that SH4-domains direct targeting to the 
intracellular leaflet of the membrane and the targeting mechanism depends on lipid 
acylation of SH4 domain (Blenis and Resh, 1993), the underlying molecular mechanism 
of intracellular transport of SH4-domain containing proteins remains elusive. In a 
previous study from our laboratory, a genome wide RNAi screen was performed using an 
automated microscopy platform to identify gene products involved in intracellular 
targeting and transport of SH4 reporter proteins to the plasma membrane. All together 
286 genes were identified in the primary genome wide screen.  
The main goal of this study was to further validate a subset gene products identified 
during the primary screen and characterize in more detail their roles in the targeting of 
SH4-domain containing proteins to the plasma membrane. Among the identified gene 
products we found factors involved in lipid metabolism, intracellular transport and 
cellular signaling processes. We used complementary approaches to confirm the 
requirements of coatomer, PKCα and MVD in the plasma-membrane targeting of SH4-
domain containing proteins. Further we focused our study on the hypothesis that NAE1 
as a component of the neddylation pathway is involved in intracellular transport of SH4-
reporter proteins. We applied RNAi-based downregulation, dominant negative constructs 
of components of the neddylation pathway; as well as a specific inhibitor against NAE1 
to block cellular neddylation and characterized the effects on SH4-dependent transport.  
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2 MATERIAL	  AND	  METHOD	  
2.1 MATERIAL	  
2.1.1 Chemicals	  and	  consumables	  
Chemical/Consumable Manufacturer 
1 kb DNA standard 
2-bromopalmitate 
Acetic acid (CH3COOH) 
New England Biolabs, Frankfurt 
Sigma-Aldrich Chemie GmbH, Steinheim 
Carl Roth GmbH, Karlsruhe 
30% acrylamide 4K solution 37,5:1 Rotiphorese Carl Roth GmbH, Karlsruhe 
Agar Becton Dickinson, Le Pont de Claix 
Agarose Invitrogen Ltd., Paisely 
Ammoniumperoxodisulphate (APS) Carl Roth GmbH, Karlsruhe 
Ammonium sulfate (NH4)2SO4 Acros organics, New Jersey 
Ampicillin Gerbu Biotechnik GmbH, Gaiberg 
NuPage Antioxidant Invitrogen Ltd., Paisely 
Aqua ad iniectabilia Braun AG, Melsungen 
Bovine serum albumin (BSA) Carl Roth GmbH, Karlsruhe 
Bromphenol blue Serva Electrophoresis GmbH, Mannheim 
buffer 4 for restriction enzymes New England Biolabs Inc. Frankfurt 
Calcium chloride Dihydrate J.T. Baker, Deventer 
Cell culture dishes ( x cm, 10 cm, 15 cm) Corning Incorporated 
Cell Dissociation Buffer (CDB) Invitrogen Ltd. Paisley 
Cell scraper Corning Incorporated 
Centrifuge tubes polyclear 25 x 89 mm Konrad Beraneck, Weinheim 
Centrifuge tubes polyclear 14 x 89 mm Konrad Beraneck, Weinheim 
Centrifuge tubes polyclear 11 x 60 mm Konrad Beraneck, Weinheim 
Chloramphenicole Carl Roth GmbH, Karlsruhe 
Chloroquine Sigma-Aldrich Chemie GmbH, Steinheim 
Collagen R Serva Electrophoresis GmbH, Heidelberg 
Complete Protease Inhibitor Cocktail tablets 
EDTA-free  
Roche Diagnostics, Mannheim 
Coomassie Brilliant blue R250 SERVA Electrophoresis GmbH 
Coomassie G-250 Carl Roth GmbH, Karlsruhe 
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CryoTubes Cryo S Greiner bio-one 
Diethylaminoethyldextran (DEAE-dextran) Sigma Aldrich Chemie GmbH, Steinheim 
Dimethyl sulphoxide (DMSO) Merck KGaA, Darmstadt 
Disodiumhydrogenphosphate (Na2HPO4) AppliChem, Darmstadt 
Dithiothreitol (DTT) Gerbu Biotechnik GmbH, Gaiberg 
Doxicycline Clontech, Heidelberg 
Eppendorf tubes 1,5 ml Sarstedt, Nümbrecht 
Ethanol p.a. Merck KGaA, Darmstadt 
Ethidium bromide Carl Roth GmbH, Karlsruhe 
Ethylenediaminetetraacetate-disodium (EDTA) SERVA Electrophoresis GmbH 
Falcon tubes 15, 50 ml Greiner bio-one 
Fetal Calf Serum (FCS) PerBio 
Filter tubes 45 µm for FACS Falcon 
Formaldehyde solution 37% J.T. Baker, Deventer 
L-Glutamine Biochrom KG, Berlin 
Glycerol J.T. Baker, Deventer 
Glycine Applichem, Darmstadt 
HisTrap HP 1ml GE Healthcare 
Hydrochloric acid (HCL) VWR Prolabo 
Imidazole Merck KGaA, Darmstadt 
Isopropyl-ß-D-thiogalactopyranoside (IPTG) Gerbu Biotechnik GmbH, Gaiberg 
Kanamycine Gerbu Biotechnik GmbH, Gaiberg 
Magnesium chloride (MgCl2) J.T. Baker, Deventer 
D-MEM Biochrom AG, Berlin 
ß-mercaptoethanol Merck KGaA, Darmstadt 
N-morpholinoethanesulfonic acid (MES) SERVA Electrophoresis GmbH 
NuPage MES buffer 20 x Invitrogen Ltd., Paisely 
Methanol Merck KGaA, Darmstadt 
Midi Gel Adapter for Criterion TM Cell Invitrogen Ltd., Paisely 
Milk powder Carl Roth GmbH, Karlsruhe 
needle 27 gauge x 3/4 0,4 mm x 19 mm BD, Drogneda, Ireland 
Neubauer Chamber W.Schreck, Hofheim 
Nonidet P 40 Roche Diagnosics, Mannheim 
NuPAGE Novex Midi Gels 4-12% Bis-Tris  Invitrogen Ltd., Paisely 
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Odyssey protein marker Precision Plus Protein All 
Blue Standards 
BioRad Laboratories GmbH, München 
Optiprep 60% Sigma-Aldrich Chemie GmbH, Steinheim 
Ortho-Phosphoric Acid H3PO4 Grüssing, Filsum 
Paraformaldehyde Riedel de Haën, Seelze 
Penicillin/Streptomycin Biochrom AG, Berlin 
Petri dishes, glass 20 cm Carl Roth GmbH, Karlsruhe 
Phenylmethylsulfonyl Fluoride (PMSF) Roche Diagnostics, Mannheim 
Pipets 5,10 and 25 ml Corning Incorporated 
Pipet tips Greiner bio-one 
Potassium chloride (KCl) AppliChem, Darmstadt 
Potassium dihydrogenphosphate (KH2PO4) GERBU GmbH, Gaiberg 
Propan-2-ol p.a. Merck KGaA, Darmstadt 
Propidium iodide (PI) Molecular probes 
PVDF membrane ImmobilonTM FL Millipore 
D (+)-Saccharose Carl Roth GmbH, Karlsruhe 
silver nitrate AgNO3 Sigma-Aldrich Chemie GmbH, Steinheim 
silver nitrate solution, 0.1 mol/l AgNO3  Grüssing, Filsum 
Sodium acetate CH3COONa Grüssing, Filsum 
Sodium carbonate anhydrous Na2CO3 AppliChem, Darmstadt 
Sodium chloride (NaCl) AppliChem, Darmstadt 
Sodium dodecyl sulphate pellets (SDS) Carl Roth GmbH, Karlsruhe 
Sodium hydrogen carbonate (NaHCO3) J.T. Baker, Deventer 
Sodium hydroxide (NaOH) J.T. Baker, Deventer 
Sodium Thiosulfate Na2S2O3 J.T. Baker, Deventer 
Superdex 75 HiLoad 16/60  GE Healthcare 
Syringe, 1ml Becton Dickinson, Le Pont de Claix 
N,N, N`N´-tetramethylethylendiamine (TEMED) Carl Roth GmbH, Karlsruhe 
Tris[hydroxymethyl]aminoethane Carl Roth GmbH, Karlsruhe 
Triton X-100 Roche Diagnostics, Mannheim 
Trypsin Biochrom KG, Berlin 
Tryptone Becton Dickinson, Le Pont de Claix 
Tween-20 Carol Roth GmbH, Karlsruhe 
Whatman 3 mm paper Whatman AG 
  Material and Method 
    
  33 
Yeast extract Becton Dickinson, Le Pont de Claix 
2.1.2 Technical	  devices	  
Technical device Manufacturer 
Agarose gel chamber BioRad Laboratories GmbH, München 
Centrifuge: Centrifuge 5417R Eppendorf AG, Hamburg 
Centrifuge: Centrifuge 5415 C Eppendorf AG, Hamburg 
Centrifuge: Centrifuge 5804R Eppendorf AG, Hamburg 
Centrifuge: Optima L80-XP Ultracentrifuge Beckman Instrument GmbH, München 
Centrifuge: Sorvall RC 12 BP Thermo Scientific 
CriterionTM Cell Midi Gel System BioRad 
CryoBox Nalgene 
FACSAria cell sorter Becton Dickinson, Le Pont de Claix 
Fluorescence platereader Spectra MAX Gemini 
XS 
Molecular Devices 
Freezer : -86°C Freezer Thermo Electron Corporation 
Gel Doc 2000 System BioRad Laboratories GmbH, München 
Incubator (bacterial cells) Haraeus, Hanau 
Incubator (eukaryotic cells) : Steri-Cycle CO2 
Incubator HEPA Class 100 
Thermo Scientific 
Incubator shaker innova 4200 New Brunswick Scientific, Edison NJ 
Laserscan microscope LSM-510 Zeiss, Göttingen 
Magnetic stirrer  Heidolph 
Microwave Panasonic 
Mini-Protean 3 III Gel System BioRad Laboratories GmbH, München 
Mini-Trans-Blot Blotsystem BioRad Laboratories GmbH, München 
Nanodrop ND-1000 Spectrophotometer Technologies, Inc. 
NuPage gel system Invitrogen Ltd., Paisely 
Odyssey imaging system LI-COR Biosciences 
pH-Meter 766 Calimatic Knick GmbH 
Pipetboy IBS Integra Biosciences 
Pipets P10, P20, P200, P1000, P10,000 Gilson 
Power supply: Power Pac 200 BioRad Laboratories GmbH, München 
Refrigerator: Premium Liebherr 
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Resys Analytical ELISA Reader 2001 Anthos Analytical Apparatus Inc., Durham 
Roto-Shake Genie Scientific Industries GmbH, München 
Scanner EPSON Perfection 3200 Photo 
Shaker: Promax 2020 Heidolph 
Sonifier B-30 Branson Sonic Power Co. 
Spinner flasks 2l Techne, Camebridge 
Sterile hood, Herasafe KS12 Thermo Scientific 
Thermocycler primus 96 advanced Peqlab Biotechnologie GmbH, Erlangen 
Thermomixer 5436 Eppendorf AG, Hamburg 
Thermomixer Comfort Eppendorf AG, Hamburg 
Vortex mixer Reax top Heidolph 
Water bath Gesellschaft für Labortechnik GmbH, Burgwedel 
2.1.3 Enzyme	  
Enzyme Manufacturer 
ECORI New England Biolabs, Frankfurt 
SalI New England Biolabs, Frankfurt 
SacII New England Biolabs, Frankfurt 
NheI New England Biolabs, Frankfurt 
XhoI New England Biolabs, Frankfurt 
T4 DNA Ligase TaKaRa Biochemical, Berkeley 
2.1.4 Kits	  
Kit Manufacturer 
BCA Protein Assay Kit Pierce 
MBS Mammalian Transfection Kit Stratagene, La Jolla 
NucleoBond PC 500 (Maxi) Macherey-Nagel, Düren 
NucleoSpin Plasmid (Mini) Macherey-Nagel, Düren 
QIAquick Gel Extraction Kit QIAGEN GmbH, Hilden 
QIAquick PCR Purification Kit QIAGEN GmbH, Hilden 
TaKaRa DNA Ligation Kit TaKaRa Biochemical, Berkeley 
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2.1.5 Antibodies	  
 
Primary antibody Manufacturer Dilution in Western Blot 
Mouse anti-HumanTransferin 
Receptor, monoclonal, Clone 
H68.4 
ZYMED Laboratories 1: 500 
Rabbit anti-Caveolin1, 
polyclonal, (N-20) SC-894 
Santa Cruz 1: 1000 
Rabbit anti-dsRED, polyclonal Clontech 1:1000 
Rabbit anti –GFP, polyclonal AG Nickel, affinity purified 1:300 
Mouse anti-GAPDH Ambion 1:4000 
Goat anti-MVD, polyclonal Santa Cruz 1:1000 
Rabbit anti-NEDD8, monoclonal EPITOMICS 1:500 
Mouse anti-PKC, monoclonal Abcam 1:3000 
Secondary antibody Manufacturer Dilution in Western Blot 
Goat anti-mouse Alexa Fluor 680 Molecular Probes, Leiden 1:5000 
Goat anti-rabbit Alexa Fluor 680 Molecular Probes, Leiden 1:5000 
Table 1 Antibodies used in the current study 
2.1.6 Plasmids	  
 
Plasmid Application Resistance Origin 
pIRES-dsRED Cloning Kanamycin Clontech 
Table 2 Plasmid used in the current study 
2.1.7 Bacteria	  and	  media	  
 
Bacteria Manufacturer 
Subcloning Efficiency DH5α Chemically 
Competent E.coli 
Invitrogen, Groningen 
Table 3 Bacteria used in the current study 
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LB-Medium:   10 g  NaCl 
    10 g  Tryptone 
    5 g  Yeast Extract 
    ad 1 l   H2O MilliQ 
For plate preparation, Agar was added with a final concentration of 16 g/l. 
 
2.2 MOLECULAR	  BIOLOGICAL	  METHODS	  
2.2.1 PCR	  
PCR is a standard method for selective amplification of nucleic acid. DNA template 
defined by a forward and reverse primer was amplified in high amounts and could be 
used for further cloning to generate desired reporter constructs.  
Following reaction mix was used for PCRs: 
Sample reaction (total 50µl) 
5 µl 10X Reaction Buffer 
5 µl MgCl2 
0,5µl Taq 
1µl dNTP 
1µl Forward Primer 
1µl Reverse Primer 
1µl DNA template 
35.5 µl H2O 
 
Thermal cycling program  
Initial denaturation 95°C for 2 min 
Denaturation  95°C for 45 sec 
Primer-annealing   Tm of primers for 1 min  30 cycles 
Elongation  72°C for 1 min 
Final elongation 72°C for 10 min 
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Name Sequence 
NAE1 443-479 for GGGGATCCGGCCAGGAGTATCTAACTATCAAG 
NAE1 443-479 rev GTAATGGTGAAAGATGATTATGTCTAGGTCGACCC 
NEDD8 for GGAATTCGCCACCATGGATTACAAGGATGACGACGATAAG 
CTAATTAAAGTGAAGACGCTGACCGGAAAGGAGATTG 
NEDD8 rev CGTCGACTCACTGCCTAAGTCCTCTCAGAGCCAACAC 
UBA3 for CGAATTCGCCACCATGGATTACAAGGATGACGACGATAAGGCTGTTGATGG 
TGGGTGTGGGGACAC  
UBA3 rev CGTCGACTTAAGAAGTAAAATGAAGTTTGAATAGTACAGTCTGTGGGGTGG 
UBC12 for CGAATTCGCCACCATGGATTACAAGGATGACGACGATAAG 
ATCAAGCTGTTCTCGCTGAAGCAGCAGA  
UBC12 rev CGTCGACCTATTTCAGGCAGCGCTCAAAGTAGGTGGAGC 
Mouse NAE1 for GAGATCTGCCTCCATGGATTACAAGGATGACGACGATAAG 
GCGCAGCCAGGGAAGATACTCAAGGA 
Mouse NAE1 rev CGTCGACCTACAACTGGAAAGTTGCAGAAGTTTGTGACATAC 
Table 4 Primers used for cloning of DNA constructs 
 
2.2.2 PCR	  purification	  
PCR products were purified by using PCR purification kit (QiaQuick PCR purification 
kit, Qiagen) following the manufacturer’s manual. An appropriate volume of MilliQ H2O 
was used for elution of the amplified DNA.  
2.2.3 Restriction	  digest	  
Restriction endonuclease was used to perform the digestion of target vectors or PCR 
products for further cloning experiments. Restriction endonuclease is an enzyme which 
cuts double-stranded or single stranded DNA at specific recognition nucleotide sequences 
(restriction sites), which vary between four and eight nucleotides, resulting sticking or 
blunt ends.  Depending on the enzyme and the quality of the DNA 1 to 5 U/µg DNA were 
used for a restriction digest. 
Sample reaction (total volume 20 µl) 
2 µl  Digestion Buffer (New England Biolab) 
5 µl DNA  
0.5 µl Digestion enzyme 
0.5 µl Digestion enzyme 
12 µl H2O  
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All the reactions were carried out at 37°C for at least 2 hours. 
2.2.4 DNA	  dephosphorylation	  
Calf Intestinal Alkaline Phosphatase (CIP, New England Biolabs), an enzyme that can 
dephosphorylate the 5´phosphat group of DNA, was applied for preventing the self-
ligation of digested vectors. The enzyme was used in a concentration of 1 U/µg DNA for 
30 min at 37°C and subsequently inactivated at 70°C for 10 min.  
2.2.5 Agarose	  gel	  electrophoresis	  
Agarose gel electrophoresis separates DNA and RNA fragments by their length. For 
visualization of the DNA, ethidiumbromide was added into the gel with a final 
concentration of 0-5 µg/ml. Agarose gels were documented using Gel Doc 2000 imaging 
system (Bio-Rad). 
Fragment Base pairs DNA mass ng 
1 10,002 42 
2 8,001 42 
3 6001 50 
4 5001 42 
5 4001 33 
6 3001 125 
7 2000 48 
8 1500 36 
9 1000 42 
10a 517 42 
10b 500 42 
Table 5 DNA marker (1kb ladder from “New England Biolabs”) 
 
2.2.6 Gel	  extraction	  of	  DNA	  fragments	  
Digested DNA was separated on a 1% agarose gel by using agarose gel electrophoresis. 
After cutting out the desired bands, QIAquick Kits were employed for purification the 
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DNA by removing enzymes, salts, agarose, ethidium bromide, and other impurities from 
DNA samples following manufacturer’s protocol.  
2.2.7 Ligation	  of	  DNA	  fragments	  	  
The enzymatic recombination of DNA fragments was performed with T4 DNA-ligase 
(Promega). The 3´-Hydroxy-End with 5´-phosphat-End 
 
Ligation into pGEMT vector 
2 µl PCR products 
1µl pGEMT Vector 
5µl Ligase buffer  
1µl T4-Ligase 
1µl H2O 
Incubation at 16°C for 45 min 
 
Ligation into pIRES-dsRED vector 
The double-stranded oligonucleotides were inserted into the vector by ligation using the 
TaKaRa Ligation Kit (TaKaRa Biochemical). The appropriate amount of insert (1:1 
molecular ratio vector to insert) can be calculated with the following equation: 
 
        amount vector [ng] x number of basepairs insert [bp] 
                                                                                                      =    amount insert [ng] 
number of basepairs vector [bp] 
 
The ligation reaction was performed following the instructions of the manufacturer and 
incubation was carried out at 16°C for 2 h. For each ligation several reaction mixes were 
created, each containing a different molecular ratio of insert to vector (1:1, 3:1, 6:1). 
A typical ligation reaction:  vector  x µl (at least 200 ng) 
     insert  x µl  
     solution I 10 µl                          
     H20  ad 20 µl 
. 
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2.2.8 DNA	  sequencing	  
Samples of 30 µl (50-100 ng/µl) were sent to GATC Biotechnology AG, Konstanz for 
sequencing. The sequencing procedure is according to the standard Sanger method 
(Sanger et al., 1977). 
2.2.9 Bacterial	  transformation	  
Chemical competent DH5α cells were used for the bacterial transformation. Fifty µl 
competent cells were mixed with the ligation mix and incubated on ice for 20 minutes. 
Subsequently, the cells were heat-shocked for 45 seconds in a water bath at 42°C and 
immediately returned to iced for 2 minutes. 950 µl LB-medium was then added to the 
cells and incubated at 37°C for 1 hour at 450 rpm in a thermo block.  
2.2.10 Isolation	  RNA	  from	  cultured	  cells	  
Isolation of RNA from cultured cells was carried out by using RNeasy Mini Kit (Qiagen). 
This kit allows the specific binding of RNA to a silica-based membrane. Following the 
manufacture’s protocol, high-quality RNA is eluted from the membrane in 30-100 µl 
water.  
2.2.11 Realtime-­‐PCR	  
RNA isolated from cultured cells was used for the cDNA synthesis. Following steps were 
used for the synthesis of cDNA from RNA:  
1µg  RNA 
2µl  oligo dT primer (Promega) 
ad 20µl H2O 
For annealing of oligo dT primer is annealed at 70°C for 10 minutes. Subsequently the 
reaction mix was placed on ice for at least 5 minutes. 
 
Extension step:  
 
6,4µl  (25 mM) MgCl2 
8µl  5X reaction buffer 
4µl  (10 mM) dNTP mix 
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1µl  Recombinant RNasin Ribonuclease Inhibitor 
1µl  ImPRom-II Reverse transcriptase 
The reverse transcription reactions were first annealed at 25°C and then incubated at 
42°C for 60 minutes and subsequently at 95°C for 5 minutes for the inhibition of reverse 
transcriptase. 
 
Realtime PCR 
TaqMan Gene Expression Assays (Applied Biosystems) were applied for the Realtime 
PCR. Predesigned gene specific probes were purchased for the performing quantitative 
gene expression studies. A reporter dye (FAMTM dye) is linked to the 5´end of the probe. 
During PCR, the TaqMan MGB probe anneals specifically to a complementary sequence 
between the forward and reverse primer sites. When the probe is intact, the proximity of 
the reporter dye to the quencher dye results in suppression of the reporter fluorescence, 
primarily by Förster-type energy transfer. Only probes hybridized to the target will be 
cleaved by the DNA polymerase. Cleavage separates then the reporter dye from the 
quencher dye, which results in increased fluorescence by the reporter. Polymerization of 
the strand continues, but because the 3´end of the probe is blocked, no extension of the 
probe occurs during PCR. GAPDH was used for as an endogenous control. 
10 µl  TaqMan Gene Expression Assays (20X)  
1.8µl  Forward primer 10µM 
1.8µl Reverse primer 10µM 
1µl TaqMan MGB probe 5µM 
4.4µl ddH2O 
1µl cDNA 
------- 
total 20 µl  
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Prepare the total RNA 
 
Perform reverse transcription 
 
Evaluation the cDNA 
 
Prepare the reaction mix and load the plate 
 
Prepare the PCR reaction mix 
 
Load the plate 
 
Run the real-time PCR reaction 
 
Run the plate 
 
Analyze the results 
2.2.12 Plasmid	  transient	  transfection	  
FuGENE HD Transfection Reagent was used for plasmid transfection. For 6-well 
transfection, 2 µg DNA was diluted to a final volume of 50 µl Opti-MEM. 4 µg FuGENE 
HD was diluted to final volume of 50 µl Opti-MEM without allowing contact with the 
walls of plastic tube. Both pre-diluted reagents were then mixed and incubated for 20 
minutes at room temperature. Thousand and four hundred µl Opti-MEM was then added 
to each well containing cells. The DNA-FuGENE HD complex were then added to the 
cells and incubated at 37°C in a CO2 incubator at least 20 hours post-transfection.  
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2.3 EUKARYOTIC	  CELL	  CULTURE	  TECHNIQUES	  
2.3.1 Maintaining	  the	  cell	  lines	  
Cells were grown at 37°C in a CO2-incubator at 100% humidity. New thawed cells were 
treated with mycoplasma Removal Agent (MP, Inc.) to avoid mycoplasma 
contamination.  MRA was added in a 1:100 (0.5” g/ml) dilution to the medium and left 
on for 7 days. 
 
PBS (Phosphate buffer saline): 
140 mM  NaCl 
2.7 mM  KCl 
10 mM  Na2HPO4 
1.8 mM KH2PO4 
2.3.2 Freezing	  of	  eukaryotic	  cells	  
After detaching cells by using Trypsin/EDTA, cells were suspended in growth medium 
and transferred to a 50 ml tube. The suspension was then centrifuged at 200 g for 3 
minutes. Cells were then suspended in 2 ml freezing medium and transferred to cryo-vial 
(Greiner) at stored at -80°C. Frozen cryo-vials were removed to liquid nitrogen tanks for 
long-term storage. 
 
Freezing medium: 
20% (w/v) FCS 
10% (w/v) DMSO 
100 ” g/ml streptomycin/penicillin 
plain DMEM 
2.3.3 Thawing	  of	  eukaryotic	  cells	  
Frozen cells were thawed at 37°C in a water bath and subsequently added to pre-warmed  
20 ml complete medium. For removing DMSO in the medium, cells were centrifuged at 
200 g for 3 minutes and suspended in complete medium. As the last step, cells were 
stored in a incubator at 37°C with 5% CO2 for maximum 6 weeks.  
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2.3.4 Doxycycline-­‐dependent	  protein	  expression	  
To induce the expression of reporter constructs by the retroviral expression vector pRev-
TRE2 containing the doxycycline-responsive element, doxycycline (Clontech) was added 
to the complete medium in a final concentration of 1 g/ml.  
2.4 SHORT	  INTERFERING	  RNA	  (siRNA)	  IN	  MAMMALIAN	  CELLS	  
2.4.1 Liquid-­‐phase	  Transfection	  of	  Mammalian	  Cells	  with	  siRNAs	  
RNA interference is an RNA-dependent gene silencing process that is controlled by 
RNA-induced silencing complex (RISC). RNAi pathway is initiated by the enzyme 
Dicer, which cleaves long double-stranded RNA into 22 nucleotide small interfering 
RNAs. The siRNAs are incorporated into a multicomponent nuclease RISC. RISC then 
uses the unwound siRNA as a guide to substrate selection and in this way causing 
specific gene silencing. 
For 6-well RNAi transfection 
10 µl of a 20 µM stock was diluted in 175 µl Opti-MEM Reduced Serum Medium. 4 µl 
Oligofectamine was then diluted to a final volume of 15 µl. Subsequently the diluted 
oligonucleotides was combined with diluted oligofectamine and incubated for 20 minutes 
at room temperature. Growth medium from the cells were removed and washed once with 
medium without serum. Thousand and three hundred µl medium without serum was then 
added to each well containing cells. The siRNA-Oligofectamine complex were then 
added to the cells and incubated at 37°C in a CO2 incubator at least 24 hours post-
transfection.  
2.4.2 Reverse	  Transfection	  of	  mammalian	  Cells	  with	  siRNAs	  
HeLa cells were seeded on coated 8-well plates or 384-well plates containing 
immobilized transfection reagent mix. For 48-60 hours knockdown time on siRNA-
coated 8-well LabTek imaging chambers (Nunc), 4000 cells were seeded in 0,35 ml 
cultivation medium on each Labtek. Medium was replaced 36 hours post-transfection to 
prewarmed DMEM containing 1 µg/ml doxycycline. For 48 hours total knockdown time 
on 384 wells siRNA arras, 120 00ß cells were seeded in 3.5 ml cultivation medium on 
each plate. 
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2.4.3 Preparation	  of	  siRNA-­‐coated	  8-­‐well	  Plates	  
For coating 8-well plates, 3 µM silencer select siRNA (Ambion) or 30 µM silencer 
siRNA (Ambion) was added to 6.5 µl of transfection mix and further incubated for 30 
minutes at room temperature. 7.25 µl gelatin solution was added to yield a fian lvolume 
of 18.75 µl. 16 µl of 18.75 µl siRNA-containing transfection mix were then diluted with 
800 µl H2O. 100 µl diluted siRNA/TXFN/gelatin mix was transferred to each well on the 
8-well plate. The solution was dried in a MiVac Concentrator (Genevac) at 50°C for 40 
minutes. Caoted 8-well plates can be sotred at room temperature in the presence of drying 
pearls (Fluka) for several months.  
Sucrose/Opti-Mem Solution: 
1.37 g sucrose in 10 ml OptiMEM 
 
0.2% gelatione solution:  
0.2 g gelatin in 100 ml H2O (heated to 56°C for 20 min, filter by 0.45 µm filter) 
 
2.5 LIVE-­‐CELL	  FLUORESCENCE	  MICROSCOPY	  
2.5.1 Widefield	  and	  Confocal	  Fluorescence	  Microscopy	  
30 minutes before imaging of live cells, prewarmed CO2 independent medium 
(Invitrogen) was used containing 0.2 µg/ml Hoechst 33342 (Sigma) for staining cell 
nuclei. Axiovert 200M flurescence microscope (Zeiss) or a LSM 510 confocal 
microscope (Zeiss) was applied for the imaging.  
2.5.2 Automated	  Widefield	  Fluorescence	  Microsocpy	  
For automated microscopy, prewarmed CO2 independent medium (Invitrogen) was used 
containing 0.2 µg/ml Hoechst 33342 (Sigma) for staining cell nuclei, subsequently 
subjected to live-cell imaging on a Scan^R screening station (Olympus). 
2.5.3 Image	  Quantification	  
We used Bodiy-Cer-Tx to identify the perinuclear area containing potential accumulation 
sites for reporter proteins. Further, we quantified the intracellular accumulation of 
reporter protein per cell. Z-stacks of cells were taken under identical parameters and 
exposure time. Only the stacks containing potential accumulation sites for reporter 
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proteins, which are marked by Bodipy-Cer in red, are considered for the calculation 
afterwards. For each stack, the intracellular accumulation site of reporter proteins was 
defined as Area of Interest (AOI). Integrated intensity of AOI and total signal of each 
slice was then measured using ImageJ. Afterwards, both values were summed up 
respectively and the percent of intracellular accumulation of reporter protein was 
calculated by the value of AOI divided by the total signal value. 
2.6 BIOCHEMICAL	  METHODS	  
2.6.1 Determination	  of	  total	  protein	  concentration	  
Determination of protein concentration was carried out by using Pierce BCA Protein 
Assay Kit (Thermo Scientific). The Pierce BCA Protein Assay is a detergent-compatible 
formulation based on bicinchoninic acid (BCA) for the colorimetric detection and 
quantitation of total protein. The macromolecular structure of protein, the number of 
peptide bonds and the presence of four particular amino acids (cysteine, cystine, 
tryptophan and tyrosine) are reported to be responsible for color formation with BCA. 
Accordingly, protein concentrations generally are determined and reported with reference 
to standards or a common protein such as bovine serum albumin (BSA). A series of 
dilutions of know concentration are prepared from the protein and assayed alongside the 
unknown before the concentration of each unknown is determined based on the standard 
curve. 
2.6.2 SDS-­‐PAGE	  (sodium	  dodecyl	  sulphate	  polyacrylamide	  gel	  electrophoresis)	  
The purpose of this method is to separate proteins according to their size and not by other 
physical feature. The electrophoretic mobility of a protein depends not only on its length 
of a polypeptide chain or its molecular weight but also on posttranslational modifications. 
The anionic detergent SDS is for the denaturation of proteins and to apply a negative 
charge to each protein. Therefore, the proteins will move towards the positive charged 
electrode while the separation. SDS binds to proteins in proportion to their mass resulting 
in an approximately uniform mass to charge ratio for most proteins. Therefore it can be 
assumed that the migration distance of a protein is directly related to its size.  
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Sample preparation 
Protein samples were boiled with 4X sample buffer at 95°C for 10 minutes. SDS-PAGE 
consists of acrylamide, bisacrylamide, SDS, Tris-Cl buffer with adjusted pH. Ammonium 
persulfate (APS) and TEMED were added when the gel was ready to be polymerized.  
4x Sample buffer: 1.25 ml 0.5 M Tris-HCl, pH 6.8 
   2.5 ml   Glycerol 
   2.0 ml   10% (w/v) SDS 
   0.2 ml   0.1% (w/v) Bromphenol blue 
   0.5 ml  14.3 M ß-Mercaptoethanol 
   3.55 ml H2OMilliQ 
SDS: (Sodiumdodecylsulfate) is an anionic detergent that denatures protein to 
polypeptides. When a protein mixed with SDS is heated at 95°C, SDS wraps the around 
the polypeptide backbone. It binds polypeptides in a constant weight ration of 1.4g/G of 
polypeptide. Intrinsic charges of polypeptides becomes negligible due to the negative 
charge contributed by SDS. As a result protein become negatively charged in proportion 
to its length.  
 
β-mercaptoethanol: is used for the reduction of disulfide bridges in protein.   
 
Preparation of Mini gels 
Separation gel was poured between two glasses fixed in a casting frame and after 
polymerization stacking gel was poured on the top of separation gel. Subsequenetly, a 
plastic comb was inserted from the top to form the loading wells. After polymerization 
the gel was ready for analysis.  
Electrophoresis was performed using the PROTEAN III system (BIO-
RAD).Electrophoresis was performed at 200 volt for about 55 minutes.  
 
Running buffer: 25 mM Tris-HCl, pH 8.3 
   192 mM Glycine 
   0.4% (w/v)  SDS 
 
  Material and Method 
    
  48 
Substance 12% separation gel 4% stacking gel 
H2O 13.4 ml 12.2 ml 
1.5 M Tris HCl pH 8.8 10 5 
SDS 10% 400 µl 200 µl 
Acrylamid/Bis 30% w/v 16 ml 2.66 ml 
APS 10% 300 µl 200 µl 
TEMED 30 µl 40 µl 
Sum 40 ml 20 ml 
Table 6 Gel solutions for 10 SDS-gels 
 
Electrophoretic separation using Midi gels (NuPAGE-System) 
4%-12% Bis-Tris gradient Midi gels (Invitrogen) were used to obtain a better resolution 
of protein bands in the low molecular weight range. These gels were used in combination 
with Midi Gel adaptors and the CriterionTM cell gel chamber (BioRad). After filling up 
with MES running buffer, 200 V was applied for approximately 45 min. 
MES running buffer: 50 ml  NuPage MES buffer 20 x 
   950 ml  H2OMilliQ 
 
In the upper buffer chamber, MES running buffer was supplemented with NuPage-
antioxidant (150µl / 60 ml running buffer) 
2.6.3 Western	  blot	  analysis	  
 
Proteins separated by SDS-PAGE were transferred to polyvinylidene fluoride (PVDF) 
membrane for immunodetection afterwards.  
Transfer to PVDF-FL membrane 
PVDF-FL membrane was activated by methanol for approximately 1 min and then 
transferred to blotting buffer. Sponges and Whatman paper were transferred into blotting 
buffer. The blotting apparatus was assembled as following order: 
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The western blot was carried out at a constant voltage of 100 V for 60 minutes. 
 
Blotting buffer: 40 mM  Glycine 
   25 mM Tris Base 
   20%  Methanol 
   H2O  ad 1x 
2.6.4 Separation	  of	  detergent-­‐resistant	  membranes	  (DRMs)	  
 
Preparation of cell lysates 
Cells were washed twice with cool PBS. Subsequently, 1 ml of 0.5 mmol EDTA/PBS 
was added to the cells and incubated at 37°C for 10 min. Cells were scraped by cell-
scraper and transferred in an eppendorf tube. After centrifugation at 400g for 3 min at 
4°C, pellets were resuspended in 100 µl PBS containing 1% Triton-X-100 with Protease 
Inhibitor Cocktail (Roche). Cells were lysed during the 30 min-incubation time on ice. 
This cell suspension was further lysed with a 27-gauge needle 14 times. Lysate was then 
centrifuged at 800 g for 5 min at 4°C.  
DRM preparation 
45 µl cell lysate was homogenized with 90 µl of 60% Optiprep by intensive vortexting 
resulting in a 40% Optiprep resolution. This fraction was loaded in the bottom of SW 
50.1 polyclear centrifuge tube (Beckman). A layer of 375 µl 28% Optiprep solution was 
loaded on the top of the last fraction. Finally, 90µl MBS 1% Triton X-100 were covered 
on the top of the gradient. By using SW 50.1 rotor (Beckman), the gradient was 
centrifuged at 100.000 g and 4°C for 3 hours. After centrifugation, 8 fractions of 45 µl 
Anode (+) 
Sponge 
1 MM Whatman 
PVDF membrane 
SDS gel 
1 MM Whatman 
Sponge 
Kathode (-) 
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were taken starting from the top of gradient. 36 µl of each fraction was loaded on SDS-
PAGE for further analysis. 
 
MBS buffer:  20 mM MES pH 6.5 (NaOH) 
   150 mM NaCl 
   1% (w/v) Triton X-100 
   Roche Protease Inhibitor Cocktail without EDTA  
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3 	  Results	  
 
 
Src proteins are non-receptor tyrosine kinases that play key roles in regulating cell 
proliferation, differentiation, migration and cell-shape changes (Brown and Cooper, 
1996; Thomas and Brugge, 1997). Src-family tyrosine kinases are composed of: (1) an N-
terminal Src homology SH4 domain conferring membrane binding via one or several 
acylations (2) a poorly conserved domain, (3) an SH3 domain binding specific proline-
rich sequences and mediating protein-protein interactions, (4) an SH2 domain, which can 
bind to specific sites of tyrosine phosphorylation, (5) an SH1 tyrosine kinase catalytic 
domain which contains an autophosphorylation site and mediates enzymatic activity (6) a 
C-terminal negative regulatory tail for autoinhibition of the kinase activity (Brown and 
Cooper, 1996; Thomas and Brugge, 1997). The N-terminal SH4 domain modified by 
fatty acylation is responsible for membrane attachment and targeting to plasma 
membranes. However, the underlying molecular mechanism of the targeting of SH4-
domain containing proteins remains elusive. In this work we aimed to validate the gene 
products identified in a previous genome wide RNAi screen and to further characterize 
their molecular functions of targeting SH4 proteins to plasma membranes. We validated 
several hits identified in the primary screen, namely COPB1, ARCN1, PRKCA, MVD 
and NAE1 by using microscopy-based RNAi screening and aimed to characterize their 
roles in trafficking of Sh4-domain-containing proteins in more detail. Further, we 
investigated the potential roles of NAE1 and cellular neddylation in SH4-domain- 
dependent trafficking to the plasma membrane. 
 
3.1 VALIDATION	   AND	   CLASSIFICATION	   OF	   GENE	   PRODUCTS	  
IDENTIFIED	  DURING	  PRIMARY	  SCREEN	  	  
 
In a previous study, a genome wide RNAi screen was performed using an automated 
microscopy platform to identify gene products involved in intracellular targeting and 
transport of SH4 reporter proteins to the plasma membrane. HeLa cells expressing fusion 
proteins of SH4-HASPB and SH4-YES in an inducible manner by doxycycline were used 
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to identify components of the transport machinery required for plasma membrane 
delivery of SH4-domain-containing proteins. To silence all around 22.000 genes of 
human genome, HeLa cells were reverse transfected with a genome-wide siRNA library 
consisting of more than 50.000 siRNAs by cultivation of cells on 384-spot siRNA arrays. 
Generated microscopy data were evaluated by applying a software-based image analysis 
module, which can detect and quantify intracellular retention of SH4 fusion proteins. All 
together 286 genes were identified in the primary screen by application of suitable score 
thresholds. In the current study, 286 genes were validated by automated microscopy-
based screen. A subset of these was subjected to manual-based validation experiments 
enabling as to validate candidate genes with a particularly strong effect on SH4-
dependent transport in a faster and more detailed approach. 
 
3.1.1 Manual	  microscopy-­‐based	  validation	  approach	  
 
We selected 12 candidate gene products identified in the primary screen that showed a 
strong intracellular retention of SH4 reporter proteins after respective siRNA treatments 
(Table 7). To validate these 12 candidate gene products, we used two independent 
siRNAs targeting different regions of each mRNA and subjected doxycycline-inducible 
HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry directly to wide field 
microscopy after siRNA treatments. With manual microscopy-based approach, we were 
able to image the cells at two different time-points, 48 hours and 60 hours post siRNA 
transfection. Manual microscopy-based validation was less time consuming compared to 
the complete validation screen of 286 gene products by using automated microscopy, 
which was done in parallel. We validated 5 gene products: NAE1, PHF5A, CCDC43 and 
GALTNL4 as well as MAK10 in the manual microscopy-based approach that showed a 
pronounced intracellular accumulation of SH4-proteins after respective siRNA treatments 
by manual inspection. 
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Gene Symbol Entrez Gene ID RefSeq siRNA ID Antisense siRNA Sequence 
ANKRD20A 84210 NM_032250 s38654 UAUGAAAAUCCCGAUUUGGAG 
ANKRD20A 84210 NM_032250 s226643 GUUGGUUCAAGUUGUUUUGCT 
ARMC8 25852 NM_014154 s24623 AACCAAACAAGGUAAUGUCTT 
ARMC8 25852 NM_014154 s24624 UAGUAGGUGAGCAAUAUUCTG 
BIN3 55909 NM_018688 s31762 AAAGAUCUUGUGCAUUUCCGA 
BIN3 55909 NM_018688 s31763 UAAGGGCUCGAUCACAGUCTT 
CCDC43 124808 NM_144609 s42802 UUUCUGACCAUCGUUCCACAA 
CCDC43 124808 NM_144609 s229298 UACGAUUUGUGCCUGCUUCTC 
C9orf116 138162 NM_001048265 s44091 UACACGGAGACAGCCUUCUGG 
C9orf116 138162 NM_001048265 s44092 UUACUGGUCCUGUACACGGAG 
EIF4A3 9775 NM_014740 s18876 UUCACGAACCUGAAUAUCCAA 
EIF4A3 9775 NM_014740 s18877 UGAUCUGCUUGAUUGCUCGTT 
FAM3C 10447 NM_001040020 s20439 AUUAUUCUUAACACCACUCAT 
FAM3C 10447 NM_001040020 s20440 UUUGUCUUAAUGCCCUUCCCA 
GALNTL4 374378 NM_198516 s51535 UGCCGGUCCACAAUGAAGCAG 
GALNTL4 374378 NM_198516 s51536 AAAGUUGUCAUAUUUGAUGTT 
MAK10 60560 NM_024635 s34135 UUUACGUACUUUGCCGUCCAT 
MAK10 60560 NM_024635 s34136 UGAACUGUAAGUAGUGCACTG 
NAE1 8883 NM_001018159 s16975 UAUACGUUUUAGGUAUUCGTC 
NAE1 8883 NM_001018159 s16976 UGGAGUAUGACUGUGGUCCTT 
NKD1 85407 NM_033119 s39961 UUUCUCCUCUCGAUGUUCUCA 
NKD1 85407 NM_033119 s39962 UUCUAUCCCGGCGAGAUCUAA 
PHF5A 84844 NM_032758 s39505 ACUCCUUACAAUAAUAGGCAT 
PHF5A 84844 NM_032758 s39506 AUAGGAGUCACAAAUCACACA 
Table 7 Manual validation approach of selected gene products from primary 
genome wide RNAi screen 
 
Manual validation approach of five gene products involved in SH4-dependent 
transport 
 
For the manual validation approach, siRNAs were coated on the 8-well Lab-Teks and 
were subsequently reverse transfected into HeLa cells expressing SH4-HASPB-GFP and 
SH4-YES-mCherry for 36 or 48 hours before protein expression was induced by 
doxycycline for additional 12 hours. Subsequently, treated HeLa cells were subjected to 
live-cell wide field microscopy to determine the localization of both SH4 fusion proteins. 
We were able to validate 5 gene products including NAE1, PHF5A, CCDC43 and 
GALTNL4 as well as MAK10 that showed a clear intracellular accumulation of SH4-
proteins after respective siRNAs treatments by manual inspection.  
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Figure 12 Characterization of NAE1 and PHF5A as components in SH4-dependent protein 
transport. HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry were reverse transfected with 
a scrambled siRNA (a-c) and a siRNA (s16975) against NAE1 (d-f) and a siRNA (s39506) against PHF5A. 
48 hours post siRNA transfection cells were subjected to live-cell wide field microscopy to determine the 
localization of both SH4 fusion proteins by manual inspection (cutouts of 10X magnification images). 
 
Figure 12 shows original wide-field microscopy data from the manual validation 
approach. HeLa SH4-HASPB-GFP and SH4-YES-mCherry cells were cultivated on 
siRNA-coated LAB-TEKs for 36 hours before protein expression was induced with 
doxycycline for additional 12 hours. Transfection of a siRNA direct against NAE1 results 
in a pronounced perinuclear retention of SH4-HASPB-GFP and SH4-YES-mCherry 
(Figure 12 d-f). NAE1 was first identified as a novel binding partner of the cytoplasmic 
domain of amyloid precursor protein (APP) and was thus called as APP binding protein 1 
(APP-BP1) (Chow et al., 1996). The interaction of APP and NAE1 was shown to activate 
Rab5-dependent endocytosis in a neddylation-independent manner (Laifenfeld et al., 
2007). In addition, NAE1 is involved in activation of the ubiquitin-like protein NEDD8 
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and participates in the neddylation pathway (Gong and Yeh, 1999). Similar to 
ubiquitination, ATP-dependent NEDD8 activation is initiated by NEDD8 E1 enzyme 
NAE1-UBA3. This heterodimer of NAE1 and UBA3 is homologous to the N- and C-
terminal domains of ubiquitin-activating enzyme, respectively (Liakopoulos et al., 1998; 
Osaka et al., 1998; Walden et al., 2003). Another validated hit PHF5A is a nuclear 
protein, which is a subunit of the splicing factor 3b complex. Treatment against PHF5A 
also causes intracellular accumulation of SH4 reporter proteins as shown in Figure 12 g-i.
 
Figure 13 Characterization of CCDC43 and GALNTL4 as components in SH4-dependent protein 
transport. HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry were reverse transfected with 
a siRNA (s42802) against CCDC43 (a-c) and a siRNA (s34135) against GALTNTL4 (d-f). 48 hours post 
siRNA transfection cells were subjected to live-cell wide field microscopy to determine the localization of 
both SH4 fusion proteins by manual inspection (cutouts of 10X magnification images). 
 
Figure 13 shows original widefield microscopy data from the manual validation 
approach. Treatment with a siRNA direct against coiled-coil domain containing 43 
(CCDC43) results in a pronounced intracellular retention of both SH4-proteins. So far the 
molecular function of CCDC43 is still unknown. A similar phenotype can be observed 
after siRNA treatment against putative polypeptide N-acetylgalactosaminyltransferase-
like protein 4  (GALNTL4), which is an integral membrane protein and localizes to Golgi 
apparatus. According to similarity analysis, GALNTL4 may catalyze the initial reaction 
in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine 
residue to a serine or threonine residue on the protein receptor. 
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Figure 14 Characterization of MAK10 as a component in SH4-dependent protein transport. HeLa 
cells expressing SH4-HASPB-GFP and SH4-YES-mCherry were reverse transfected with a siRNA 
(s34135) against MAK10 (a-c). 48 hours post siRNA transfection cells were subjected to live-cell wide 
field microscopy to determine the localization of both SH4 fusion proteins by manual inspection (cutouts of 
10X magnification images). 
 
Figure 14 shows original wide-field microscopy data from the manual validation 
approach. Treatment with a siRNA direct against N-alpha-acetyltransferase 35, NatC 
auxiliary subunit (MAK10) results in a pronounced intracellular retention of both SH4-
proteins. MAK10 is a component of the N-terminal acetyltransferase C (NatC) complex 
and may catalyze acetylation of N-terminal methionine residues according to similarity 
analysis.  
 
3.1.2 Automated	  microscopy-­‐based	  validation	  approach	  
All together 286 genes identified in the primary screen were subjected to an automated 
microscopy-based validation screen (Ritzerfeld et al., 2011). HeLa cells expressing SH4-
HASPB-GFP and SH4-YES-mCherry were cultivated on siRNA-coated 96-well plates 
for 36 hours before protein expression for additional 12 hours. Subsequently the cells 
were subjected to automated fluorescence microscopy and further analyzed using the 
automated image analysis tool (Remmele et al., 2008). Table 8 and Table 9 show the 
comprehensive list of 54 gene products, which are validated to be involved in 
intracellular transport of SH4-proteins. Validated gene products were classified into 
different groups according to the function, subcellular localization and membrane 
association. Factors involved in protein transport, lipid homeostasis and protein 
modifications were identified in the validation screen (Ritzerfeld et al., 2011). 
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A software-based image analysis tool to detect and quantify intracellular 
retention of SH4 fusion proteins 
The challenges of automated image analysis are how to correctly recognize and segment 
individual cells. The software must identify the cells, determine their shape and 
subsequently segment each cell into different subcellular compartments. For the 
recognition, stained cell nuclei are detected by an adaptive threshold approach based on 
the Hoechst channel images. Using cell nuclei as a seeding point, cells are identified and 
subdivided into three different compartments: membrane, cytoplasm and nucleus 
(Remmele et al., 2008). The three subcellular compartments are determined according to 
following rules: nucleus is defined in the region-growing approach; cell membrane is 
defined by a specific pixel width touching the cell boundary defined in the region-
growing approach; cytoplasm is comprised of the residual area of the cell which is not 
attributed to the nucleus or the cell membrane (Remmle, et al., 2008). Cell boundaries 
were identified by a region-growing approach by two criteria: (1) when intensity 
difference of GFP fluorescence within and outside of the cells is large, (2) when the 
intensity of outer pixels is lower than the intensity threshold of a given cell (Figure 15 a). 
For classification of individual cells, intensity features from the cell as well as the three 
cellular compartments were extracted and used (Remmele et al., 2008; Ritzerfeld et al., 
2011). Thus a perinuclear retention of SH4-reporter proteins in the Golgi region as an 
example would be classified as a hit because Golgi membranes result in an increased 
cytoplasmic intensity compared to nuclear and membrane-associated intensities. 
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Figure 15 Cell segmentation and classification using an automated image analysis tool. (A) Individual 
cells were segmented into three different compartments: the plasma membrane, the cytoplasm and the 
nucleus. (B) Intensity features were extracted for the whole cell area and for each compartment and used 
for cell classification (Ritzerfeld et al., 2011). 
 
 
Calculation of scores from classification results derived from the automated image 
analysis tool 
We determined the percentage of cells displaying phenotypes and calculated the standard 
deviation of a complete array (all 384 spots on the same plate), which is used to 
determine a score for each experimental condition. These two values were used to 
calculate the distance of the respective spot´s percentage to the median in standard 
deviations of the same plate. This distance is expressed in scores. Scores above 2.5 and 
3.5 for SH4-HASPB-GFP and SH4-YES-mCherry were used for primary screen, 
respectively. For the automated validation approach, median and standard deviation from 
all negative controls calculated on the same LabTek were used for the determination of 
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scores. Be regarding scores above 2 as hits for both SH4-reporter proteins, we were able 
to validate 54 gene products, whose downregulation had an impact on intracellular 
transport of SH4-domain-containing proteins (Table 8; Table 9). 
 
 
Table 8 Validated gene products with putative functions in the plasma-membrane 
targeting of SH4-proteins (part 1). 
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Table 9 Validated gene products with putative functions in the plasma-membrane 
targeting of SH4-proteins (part 2). 
 
It is apparent from both manual and automated validation approaches a large number of 
gene products are identified as hits required for the intracellular trafficking of SH4 
proteins. However, considering the knowledge on the hits, which is quite often limited, 
for example PHF5A is located in the nucleus or the function of CCDC43 is completely 
unknown, we decided to focus the current study on COPB1, PRKCA and MVD as well 
as NAE1.   
  Results 
    
  61 
3.2 ANALYSIS	  OF	  COATOMER	  AS	  A	  COMPONENT	  OF	  SH4-­‐DOMAIN-­‐
DEPENDENT	  PROTEIN	  TARGETING	  
 
Previous studies on palmitoylation suggested that bulk palmitoylation occurs on the 
Golgi and this organelle provides directionality in the acylation cycle by allowing locally 
palmitoylated proteins to enter the secretory pathway from where they are targeted to the 
plasma membrane (Rocks et al., 2010). We tested the hypothesis that the general 
components of intracellular transport specifically the heterooligomeric coatomer complex 
might be required for correct targeting of SH4-proteins. siRNA-mediated down-
regulation of the COPB1 gene consistently resulted in perinuclear retention of SH4-
fusion proteins and knockdown of ARCN1 (COPD) caused a similar phenotype. 
Moreover, knockdown of coatomer subunits did not affect SH4-protein trafficking when 
HeLa cells were microinjected with recombinant coatomer. Thus, our observations 
propose that COPB1 as a component of a multi-protein complex plays an important role 
in SH4-dependent protein transport. 
3.2.1 RNAi	  mediated	  down-­‐regulation	  of	  coatomer	  subunits	  causes	  
intracellular	  accumulation	  of	  SH4-­‐proteins	  	  
 
The coatomer subunits COPB1 (β-COP) and COPA (α-COP) were identified and 
validated as essential components for the cellular targeting of SH4 fusion proteins to the 
plasma membrane.  
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Figure 16 Knockdown of coatomer subunit COPB1 and COPD cause intracellular retention of SH4-
proteins. HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry were transfected with a 
scrambled siRNA (a-c), a siRNA against COPB1 (d-f) and a siRNA against COPD. 48 hours post siRNA 
transfection cells were subjected to live-cell wide field microscopy to determine the localization of both 
SH4 fusion proteins. 
 
 
Figure 16 shows that transfection of siRNA against coatomer subunits COPB1 (panel d-f) 
and COPD (panel g-i) cause a pronounced intracellular retention of SH4-proteins 
compared to the treatment with a scrambled siRNA (panel a-c). In following experiment, 
we took the advantage of the strong phenotype after treatment with siRNA against 
COPB1 and used it as positive control for the following investigations. 
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3.2.2 Determination	  of	  knockdown	  efficiencies	  of	  coatomer	  subunits	  on	  
protein	  level	  
 
As mentioned in the previous section, we employed siRNA mediated knockdown against 
coatomer subunits to study the intracellular localization of SH4-proteins. Each siRNA 
was transfected for 48 hours followed by analysis of GFP, COPB1 and COPD on protein 
level. 
 
A 
 
 
 
 
 
 
 
B 
 
 
Figure 17 Determination of knockdown efficiencies of coatomer subunits on protein level. Sixty µg 
protein of total cell lysates of HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry were 
subjected to SDS-PAGE and Western blot (A). Antibodies against GFP, beta-COP, delta-COP and GAPDH 
were used for the detection on Western blot and further for the quantification of siRNA knockdown 
efficiencies on protein level (B). 
 
Efficiencies of down-regulation of coatomer subunits COPB1 and COPD were 
determined at the protein level. GFP was down regulated as a positive control. Around 
30%, 40% and 20% of GFP, COPB1 and COPD protein remained after down-regulation 
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with respective siRNAs (Figure 17). Downregulation of COPB1 caused also a loss of 
COPD and vice versa (Ritzerfeld et al., 2011).  
3.2.3 Rescue	  experiment	  with	  recombinant	  coatomer	  
To address whether intracellular retention evoked by knockdown of coatomer subunits 
was indeed a result of depletion of the coatomer protein complex, we microinjected stable 
HeLa cells expressing SH4-HASPB-mCherry with recombinant coatomer before RNAi 
treatment against COPB1.  
 
Figure 18 Rescue experiment by microinjection of recombinant coatomer. HeLa cells expressing SH4-
HASPB-mCherry were microinjected with recombinant coatomer and an Alexa-488-labelled secondary 
antibody before transfection with a siRNA against COPB1. Post-transfection 30 hours, live-cell confocal 
microscopy was applied for the analysis of subcellular localization of the SH4 fusion protein. 
 
As shown in Figure 18 d-f, the intracellular accumulation of SH4-HASPB-mCherry 
caused by silencing of COPB1 is prevented by microinjection of recombinant coatomer. 
Control cells microinjected with buffer upon knockdown of COPB1 show intracellular 
retention of SH4-HASPB-mCherry (Figure 18 a-c). These results demonstrate that 
coatomer is involved in proper targeting of SH4-HASPB to the plasma membrane 
(Ritzerfeld et. al., 2011). 
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3.3 ANALYSIS	  OF	  PROTEIN	  KINASE	  C	  ALPHA	  AS	  A	  COMPONENT	  OF	  
SH4-­‐DOMAIN-­‐DEPENDENT	  PROTEIN	  TARGETING	  
 
Recent studies postulated that phosphorylation of SH4-domain-containing proteins such 
as SRC kinases can regulate endosomal recycling (Sandilands et al., 2004; Sandilands 
and Frame, 2008; Tournaviti et al., 2007). Remarkably, protein kinase C alpha (PRKCA) 
was identified as a gene product whose down-regulation caused perinuclear accumulation 
of SH4 fusion proteins. To test whether PKC activity is required for the correct targeting 
of SH4-proteins to the plasma membrane, HeLa cells were further treated with protein 
kinase c inhibitor GÖ 6983, which also resulted in a pronounced intracellular 
accumulation of SH4-proteins. 
3.3.1 RNAi	  mediated	  down-­‐regulation	  of	  PKCα	  causes	  intracellular	  
accumulation	  of	  SH4-­‐proteins	  	  
 
We employed siRNA treatment directed against PKCα to study the intracellular 
localization of SH4-proteins. 
Figure 19 Characterization of PKCα as a component in SH4-dependent protein transport. HeLa cells 
expressing SH4-HASPB-GFP and SH4-YES-mCherry were transfected with a scrambled siRNA (a-c) and 
a siRNA against PRKCA (d-f). 48 hours post siRNA transfection cells were subjected to live-cell wide 
field microscopy to determine the localization of both SH4 fusion proteins. 
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Figure 19 shows treatment of siRNA against PKCα causes a pronounced intracellular 
retention of SH4-proteins (panel d-f) compared to the treatment with a scrambled siRNA 
(panel a-c) (Ritzerfeld et al., 2011). PKCα belongs to PKC family; a family of 
serine/threonine kinases that are involved in a variety of cellular processes, such as cell 
adhesion and cell cycle checkpoint.  
3.3.2 Determination	  of	  knockdown	  efficiency	  of	  PKCα	  on	  protein	  level	  and	  
mRNA	  level	  
 
We employed siRNA mediated knockdown against PKCα to study the intracellular 
localization of SH4-proteins. Each siRNA was transfected for 48 hours followed by 
analysis of GFP and PKCα on protein as well as mRNA level by RT-qPCR. 
 
A 
B 
 
Figure 20 Determination of knockdown efficiencies of PKCα on protein level. Sixty µg protein of total 
cell lysates of HeLa cells expressing SH4-HASPB-GPP and SH4-YES-mCherry were loaded to SDS-
PAGE and Western blot (A). Antibodies against GFP, PKCα and GAPDH were used for the detection on 
Western blot and further for the quantification of siRNA knockdown efficiencies on protein level (B).  
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Figure 20 showed GFP was down regulated as a positive control. Around 70% and 20% 
of GFP and PKCα protein remained after down-regulation with respective siRNAs  
 
 
Figure 21 Determination of knockdown efficiency of PKCα on mRNA level. mRNA level of PKCα was 
quantified by Realtime-qPCR in HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry. Graphs 
indicate relative mRNA levels after 48h in cells treated with respective siRNAs.  
 
Figure 21 shows the reduction of PKCα on mRNA level after treatment with siRNA 
against PKCα for 48 hours in HeLa cells expressing SH4-HASPB-GFP and SH4-YES-
mCherry. Around 20% of PKCα on mRNA level remained in the cells after treatment 
with a siRNA directed against PKCα compared to the treatment with a scrambled siRNA. 
 
3.3.3 Inhibitor	  GÖ	  6983	  of	  PKC	  causes	  a	  pronounced	  intracellular	  accumulation	  
of	  SH4-­‐proteins	  
 
In order to investigate whether the activity of PKC is required for targeting of SH4 
proteins to the plasma membrane, we treated cells with the pharmacological inhibitor GÖ 
6983 of protein kinase C and observed the intracellular localization of SH4 reporter 
proteins. 
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Figure 22 Incubation with inhibitor GÖ 6983 of PKC causes a pronounced intracellular 
accumulation of SH4-proteins. 10 µM inhibitor GÖ 6983 was incubated for 16 hours with HeLa cells 
expressing SH4-HASPB-GFP and SH4-YES-mCherry and subsequently analyzed by confocal microscopy.  
 
As shown in Figure 22, incubation with GÖ 6983 for 16 hours results a pronounced 
intracellular accumulation of SH4 reporter proteins similar to the RNAi treatment against 
PKCα. These results indicate that activity of PKC is required for the correct targeting of 
SH4 reporter proteins to the plasma membrane (Ritzerfeld et al., 2011).  
 
3.4 INVESTIGATION	  OF	  THE	  ROLE	  OF	  LIPID	  HOMEOSTASIS	  IN	  SH4-­‐
DOMAIN-­‐DEPENDENT	  PROTEIN	  TARGETING	  
 
A task of the study was to identify enzymes that play key roles in lipid biosynthesis and 
homeostasis. Among the results, mevalonate pyrophosphate decarboxylase (MVD), a key 
factor of cholesterol biosynthesis that generates active isoprene was identified and 
validated in the automated validation approach. MVD is a cytosolic homodimer and plays 
a role in early steps of cholesterol biosynthesis where it catalyzes the conversion of 
mevalonate pyrophosphate into isopentenyl pyrophosphate and dehydrates its substrate 
under the consumption of ATP (Hogenboom et al., 2002; Hogenboom et al., 2003; Toth 
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and Huwyler, 1996). Downregulation of MVD indeed caused reduced cellular cholesterol 
levels that were concomitant with intracellular retention of SH4 proteins. Further, we 
conducted experiments to test the hypothesis that homeostasis of cholesterol as a raft 
lipid is required for the correct targeting of SH4 proteins to plasma membrane.  
 
3.4.1 RNAi	  mediated	  down-­‐regulation	  of	  MVD	  causes	  a	  pronounced	  
intracellular	  accumulation	  of	  SH4-­‐proteins	  
 
We employed siRNA treatment directly against MVD to study the intracellular 
localization of SH4-proteins. 
 
 
Figure 23 Characterization of MVD as a component in SH4-dependent protein transport. HeLa cells 
expressing SH4-HASPB-GFP and SH4-YES-mCherry were transfected with a scrambled siRNA (a,e) and 
a siRNA against MVD (b,f) and 48 hours post siRNA transfection cells were subjected to live-cell wide 
field microscopy to determine the localization of both SH4 fusion proteins. 
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Figure 23 shows siRNA treatment against MVD causes a pronounced intracellular 
retention of SH4-proteins (panel e-f) compared to the treatment with a scrambled siRNA 
(panel a-b) (Ritzerfeld et al., 2011). MVD is a cytosolic homodimer and plays a role in 
early steps of cholesterol biosynthesis where it catalyzes the conversion of mevalonate 
pyrophosphate into isopentenyl pyrophosphate and dehydrates its substrate under the 
consumption of ATP (Hogenboom et al., 2002; Hogenboom et al., 2003; Toth and 
Huwyler, 1996). 
3.4.2 Determination	  of	  knockdown	  efficiency	  of	  MVD	  on	  protein	  and	  mRNA	  
level	  
 
As mentioned in the previous section, we employed siRNA mediated knockdown against 
MVD to study the intracellular localization of SH4-proteins. Each siRNA was transfected 
for 48 hours followed by analysis of GFP and MVD on protein as well as mRNA level by 
RT-qPCR. 
A 
 
B 
 
Figure 24 Determination of knockdown efficiency of MVD on protein level. Sixty µg protein of total 
cell lysates of HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry were subjected to SDS-
PAGE and Western blot (A). Antibodies against GFP, MVD and GAPDH were used for the detection on 
Western blot and further for the quantification of siRNA knockdown efficiency on protein level (B). 
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Figure 24 shows the reduction of MVD on protein level after treatment with siRNA 
against MVD for 48 hours in HeLa cells expressing SH4-HASPB-GFP and SH4-YES-
mCherry. Around 50% MVD on protein level remained in the cells compared to 
treatment with a scrambled siRNA. We used siRNA against GFP as a positive control 
and as shown in Figure 24 B the knockdown efficiency of GFP is around 20%.  
 
 
Figure 25 Determination of knockdown efficiency of MVD on mRNA level. mRNA level of MVD were 
quantified by Realtime-qPCR in HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry. Graphs 
indicate relative mRNA levels after 48h in cells treated with various siRNAs.  
 
As shown in Figure 25 around 20% of MVD mRNA remained in the cells expressing 
SH4-HASPB-GFP and SH4-YES-mCherry 48 hours after treatment with a siRNA 
directed against MVD comparing to the treatment with a scrambled siRNA.  
 
Together, these experiments indicate a requirement for MVD in correct targeting of SH4 
reporter proteins to the plasma membrane. Further, our results also indicate that the 
turnover of MVD protein was a relative slow process since only 20% of MVD mRNA 
compared to around 50% MVD protein remained in the cell after 48 hours treatment with 
siRNA against MVD. 
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3.4.3 Role	  of	  cellular	  cholesterol	  levels	  in	  the	  SH4-­‐domain	  dependent	  
trafficking	  
 
Since we observed the knockdown of MVD caused intercellular retention of SH4 proteins 
and MVD is the enzyme involved in cholesterol synthesis, we further challenge the 
hypothesis that cholesterol homeostasis is essential for targeting of SH4-proteins to the 
plasma membrane. 
     
 
Figure 26 MβCD treatment causes intracellular retention of SH4 proteins. To deplete cholesterol 
level, cells were incubated for 1 hour in 5/10 mM methyl-β-cyclodextrin (MβCD). Subsequently, medium 
containing MβCD was removed and fresh medium containing water-soluble cholesterol was added to the 
cells for 1 hour. Further, live-cell confocal microscopy was applied directly after the treatment.  
 
We employed MβCD to disrupt lipid rafts by removing cholesterol from membranes. 
After a one-hour treatment with MβCD, a pronounced intracellular accumulation of SH4 
reporter proteins is observed by confocal microscopy (Figure 26). Further, to test whether 
  Results 
    
  73 
accumulation was indeed a direct result of cholesterol depletion, we incubated cells with 
water-soluble cholesterol for cholesterol replenishment. Water-soluble cholesterol is 
known to form soluble inclusion complexes between MβCD with cholesterol and thereby 
enhancing the solubility of cholesterol. This treatment resulted in a pronounced re-
distribution of both SH4-HASPB-GFP and SH4-YES-mCherry. To test the possibility 
that the MβCD caused a pleiotropic effect on SH4 protein trafficking to the plasma 
membrane, we used oubain as a negative control, an unrelated inhibitor blocking the 
activity of NA+/K+ ATPase. There we also observed a mild morphology change of cells, 
however, compared to MβCD treatment, a perinuclear accumulation of SH4 reporter 
proteins is not observed (Figure 26). 
 
 
Figure 27 Determination of cellular cholesterol levels. Cholesterol / PC ratios were measured by using 
nano-electrospray ionosation mass spectrometry as described in Merz et al, 2011. Following treatment of 
cells with either a siRNA against MVD or treatment with MβCD, lipid analysis was performed from both 
whole cells and cellular membranes. 
 
We measured the cellular cholesterol levels by nano-electrospray ionization mass 
spectrometry using phosphatidylcholine (PC) as a bulk lipid to normalize data (Ritzerfeld 
et al., 2011). Cholesterol levels were reduced to 70% after 48 hours treatment of a siRNA 
directed against MVD (Figure 27). One-hour incubation of 10 mM MβCD resulted in 
pronounced intracellular retention of SH4 proteins, concomitant with a 50% reduction of 
cellular cholesterol relative to PC.  
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Our combined results suggest interference with cellular cholesterol levels results in 
pronounced intracellular retention of SH4-proteins and further corroborate the role of 
cholesterol dependent lipid rafts in SH4-domain-dependent protein targeting to the 
plasma membrane (Ritzerfeld et al., 2011). 
 
3.5 INVESTIGATION	  OF	  A	  POTENTIAL	  ROLE	  OF	  NAE1	  IN	  SH4-­‐
DOMAIN-­‐DEPENDENT	  PROTEIN	  TARGETING	  
 
In the manual validation approach, we found that the knockdown of NAE1 caused a 
pronounced intercellular retention of SH4 proteins (Figure 28). NAE1 was first identified 
as a novel binding partner of the cytoplasmic domain of amyloid precursor protein (APP) 
and thus called as APP binding protein1 (APP-BP1) (Chow et al., 1996). In addition, 
NAE1 is involved in activation of the ubiquitin-like protein NEDD8 and participates in 
the neddylation pathway (Gong and Yeh, 1999). Furthermore, NAE1 also binds and co-
localizes with amyloid precursor protein (APP) in membrane lipid rafts (Chen et al., 
2003). We challenged the hypothesis that not only NAE1 and but also a functional 
cellular neddylation pathway and its interacting partners are also involved in the SH4-
protein targeting to the plasma membrane.  
3.5.1 Validation	  analysis	  of	  siRNA	  treatments	  against	  NAE1	  and	  its	  functional	  
interaction	  partners	  NEDD8	  and	  APP	  
 
To study molecular functions of NAE1 in plasma membrane targeting of SH4 protein, we 
treated HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry with respective 
siRNA against NAE1 and its functional interaction partners NEDD8 and APP as the first 
approach.  
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Figure 28 Characterization of NAE1, NEDD8 and APP as components in SH4-dependent protein 
transport. HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry were reverse transfected with 
a scrambled siRNA (a-c), a siRNA against NAE1 (b-f) and a siRNA against APP (j-i). 48 hours post 
siRNA transfection cells were subjected to live-cell wide-field microscopy to determine the localization of 
both SH4 fusion proteins (cutouts of 10X magnification images). 
 
Figure 28 shows wide-field microscopy images of HeLa cells expressing SH4-HASPB-
GFP and SH4-YES-mCherry, which were transfected with respective siRNAs against 
NAE1, NEDD8 and APP for 36 hours before protein expression was induced by 
doxycline for additional 12 hours. A moderate perinuclear retention of SH4 fusion 
proteins can be observed after siRNA treatments against NEDD8 and APP. siRNA 
treatment against NAE1 caused a pronounced intracellular accumulation of SH4 fusion 
proteins.  
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3.5.2 Determination	  of	  knockdown	  efficiencies	  of	  NAE1,	  NEDD8	  and	  APP	  on	  
mRNA	  level	  	  
 
As mentioned in the previous section, we employed siRNA mediated knockdown against 
NAE1, NEDD8 and APP to study the intracellular localization of SH4-proteins. Each 
siRNA was transfected for 48 hours followed by analysis of NAE1, NEDD8 and APP on 
mRNA level by RT-qPCR. 
 
Figure 29 Determination of knockdown efficiencies of NAE1, NEDD8 and APP on mRNA level. The 
mRNA levels of NAE1, NEDD8 and APP were quantified by Realtime-qPCR in HeLa cells expressing 
SH4-HASPB-GFP and SH4-YES-mCherry. Graphs indicate relative mRNA levels after 48h in cells treated 
with various siRNAs. 
 
The reduction on mRNA level is quantified by using Realtime-qPCR and as shown in 
Figure 29 around 15% of NAE1, 15% NEDD8 and 30% of APP mRNA remained in the 
cells 48 hours post transfection with respective siRNAs. 
3.5.3 Analysis	  of	  wide	  field	  microscopy	  data	  with	  the	  automated	  image	  
analysis	  tool	  
 
An automated image analysis tool was developed for the identification of phenotypic 
changes with regard to the localization of SH4-reporter proteins (Remmle et al., 2008). 
We used this automated image analysis tool to analyze the intracellular distribution of 
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SH4-reporter proteins after siRNA treatments against NAE1, NEDD8 and APP for 48 
hours and 72 hours, respectively. 
Figure 30 Hit scores of siRNA treatments against NAE1, NEDD8 and APP by an automated image 
analysis tool. 48 hours after transfection with scrambled siRNA and respective siRNAs against COPB, 
PHF5A, NAE1 and APP, live-cell wide-field microscopy data were analyzed by an automated image 
analysis tool to determine the hit scores. The green line indicates the average score of treatment with 
scrambled siRNA in SH4-HASPB-GFP. The red line indicates the average score of treatment with 
scrambled siRNA in SH4-YES-mCherry. 
 
Figure 30 shows an automated image analysis result of HeLa cells expressing SH4-
HASPB-GFP and SH4-YES-mCherry after respective RNAi treatments 48 hours post 
transfection. Treatment with siRNA against NAE1 in SH4-YES-mCherry resulted an 
average score of 4, which is higher than average scores caused by siRNAs against COPB 
and PHF5A as positive controls. In SH4-HASPB-GFP, treatment with siRNA against 
NAE1 resulted an average score above 2.0, which is close to the average score of PHF5A 
as a positive control. Treatments with siRNAs against NEDD8 and APP showed low 
scores in both SH4-reporter proteins. These results suggest that NAE1 might be required 
for the correct targeting of SH4-YES. 
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Figure 31 Hit scores of siRNA treatments against NAE1, NEDD8 and APP by an automated image 
analysis tool. 72 hours after transfection with scrambled siRNA and respective siRNAs against COPB, 
PHF5A, NAE1 and APP, live-cell wide-field microscopy data were analyzed by an automated image 
analysis tool to determine the hit scores. The green line indicates the average score of treatment with 
scrambled siRNA in SH4-HASPB-GFP. The red line indicates the average score of treatment with 
scrambled siRNA in SH4-YES-mCherry. 
 
Figure 31 shows an automated image analysis result of HeLa cells expressing SH4-
HASPB-GFP and SH4-YES-mCherry after respective RNAi treatments 72 hours post 
transfection. Treatment with siRNA against NAE1 did not result in a high score after 72 
hours post transfection. Treatment with siRNA against NEDD8 resulted in the score of 
around 1,0 in SH4-HASPB-GFP and SH4-YES-mCherry, which are comparable to the 
scores gained by the positive controls. Treatment with siRNA against APP showed low 
scores in both SH4-reporter proteins. Scores for positive controls gained in this 
experiment are generally low due to the fact that cells might undergo apoptosis with 
extended knockdown time for 72 hours.  
Taking together, transfection with respective siRNAs targeted against NAE1, NEDD8 
and APP resulted in efficient reduction of the respective mRNA levels. Knockdown of 
NAE1 and NEDD8 resulted in an intracellular accumulation of SH4-YES-mCherry with 
48h and 72h knockdown periods, respectively. In SH4-HASPB-GFP knockdown of 
NEDD8 for extended period of 72h also caused comparable scores as for positive 
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controls. It might be that NAE1 and NEDD8 affected more in the trafficking of SH4-YES 
than SH4-HASPB. This could indicate that the fact that SH4-YES and SH4-HASPB 
traffic along different routes. Finally, knockdown of APP resulted low scores for both 
48h and 72h periods and in both SH4-reporter proteins.  
 
3.5.4 DRM	  association	  of	  HASPB-­‐N18-­‐GFP	  after	  diverse	  siRNAs	  treatments	  
with	  NAE1,	  NEDD8	  and	  APP	  
 
Previous studies suggested that SH4 protein trafficking was dependent on cholesterol-
dependent membrane microdomains (Brown and London 1998; Webb et al. 2000; Edidin 
2003; Smotrys and Linder 2004; Linder and Deschenes 2007). In addition, it has been 
proposed lipid rafts are required as sorting and transport platforms for the correct 
targeting of SH4 proteins. Studies about NAE1 showed that NAE1 binds APP and 
colocalize with APP in lipid rafts, a cell surface protein with signal transducing properties 
(Chen et al., 2003). Combining these two facts, we hypothesize the colocalization of 
NAE1 and APP in lipid rafts could directly influence the DRM association of SH4-
reporter proteins and thus influence raft-dependent transport to the plasma membrane. 
There is also a possibility that NAE1 might colocalize with SH4-proteins in lipid rafts 
and thus increase their affinity to lipid rafts. To answer these questions, we transfected 
the HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry with respective 
siRNAs against NAE1, NEDD8 and APP and observed the association of SH4-HASPB-
GFP with DRMs.  
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Figure 32 Plasma membrane versus intracellular localization of SH4-HASPB-GFP correlates with 
the degree of association with DRMs after respective siRNA treatments. (A) HeLa cells expressing 
SH4-HASPB-GFP and SH4-YES-mCherry were treated with respective siRNAs. Subsequently, floatation 
of cell material with Optiprep was performed. Eight fractions were collected and analyzed by SDS-PAGE. 
Caveolin-1 and Transferrin receptor were used as a DRM-marker and non-DRM marker, respectively. (B) 
Quantitative analysis of the relative distribution of the fusion protein indicated within the flotation gradient. 
Antibody signals in each fraction were quantified and further expressed as the percentage of the total 
material recovered from all fractions. 
 
As shown in Figure 32 we did not observe a significant difference on DRM association of 
SH4-HASPB-GFP after respective siRNA treatments against NAE1, NEDD8 or APP 
compared to negative controls. These results suggest that presences of NAE1, NEDD8 
and APP might be not required for the DRM association of SH4-HASPB-GFP. 
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3.5.5 Wide-­‐field	  microscopy	  analysis	  under	  RNAi	  treatments	  with	  diverse	  
siRNAs	  in	  SH4-­‐YES-­‐GFP	  
 
According to results by applying the automated image analysis tool, we could conclude 
the knockdown of NAE1 and NEDD8 have a stronger effect on trafficking of SH4-YES 
than SH4-HASPB. To further elucidate the requirements of NAE1 and its interaction 
partners for the plasma membrane targeting of SH4-YES, we further involved a cell line 
expressing SH4-YES-GPF for our study. 
 
 
Figure 33 Characterization of NAE1, NEDD8 and APP as components in SH4-YES dependent 
protein transport. HeLa cells expressing SH4-YES-GFP were reverse transfected with a scrambled 
siRNA, a siRNA against NAE1 and a siRNA against APP. 48 hours post siRNA transfection cells were 
subjected to live-cell wide-field microscopy to determine the localization of SH4-YES-GFP. 
 
Figure 33 shows wide field microscopy images of HeLa SH4-YES-GFP, which were 
transfected with respective siRNAs against NAE1, NEDD8 and APP for 36 hours before 
protein expression was induced for additional 12 hours. Significant perinuclear retention 
of SH4-YES-GFP can be observed after siRNA treatment against NAE1. Treatments with 
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siRNAs against NEDD8 and APP caused a moderate perinuclear accumulation of SH4-
YES-GFP. 
 
Figure 34 Hit percentages after siRNA treatments with PHF5A, NAE1, NEDD8 and APP by 
automated image analysis tool. 48 hours after transfection with scrambled siRNA and respective siRNAs 
against PHF5A, NAE1, NEDD8 and APP, live-cell wide-field microscopy data were analyzed by an 
automated image analysis tool to determine the hits percentage of total. The green line indicates the average 
score of treatment with scrambled siRNA in SH4-YES-GFP. 
 
Figure 34 shows hit percentages of HeLa cells expressing SH4-YES-GFP after siRNA 
treatments with PHF5A, NAE1, NEDD8 and APP by automated image analysis tool. 
Around 13% of HeLa cells expressing SH4-YES-GFP treated by scrambled siRNA are 
identified as hits. As a positive control, around 25% of HeLa cells expressing SH4-YES-
GFP after a treatment with siRNA against PHF5A are identified as hits. Around 23% of 
the HeLa cells expressing SH4-YES-GFP after siRNA treatment against NAE1 are 
regarded as hits, which is comparable to the positive control PHF5A. Around 15% and 
17% of the HeLa cells expressing SH4-YES-GFP after siRNA treatment against NEDD8 
and APP are identified as hits, respectively, which are close to the value of negative 
control.  
Overall, results shown here are in accordance with the results by using HeLa cells 
expressing SH4-HASPB-GFP and SH4-YES-mCherry (Figure 30). It seems that NAE1 
might be required in the trafficking of SH4-YES to the plasma membrane since the value 
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caused by siRNA treatment against NAE1 is comparable to the positive control in both 
experiments. However, we were not able to ascertain that APP or NEDD8 is required in 
the trafficking of both SH4-reporter proteins. 
 
3.5.6 Rescue	  Experiment	  with	  mouse	  homolog	  NAE1	  
To address whether intracellular retention evoked by knockdown of NAE1 was indeed a 
result of depletion of NAE1 protein, we transiently transfected HeLa cells expressing 
SH4-YES-GFP with mouse homolog pIRES NAE1-dsRED before siRNA treatment 
against human NAE1 and subsequently monitored the intracellular localization of SH4-
YES. The expression of dsRED visualized the transfected cells in red color.  
 
 
Figure 35 Rescue experiment by transient transfection of mouse homolog. NAE1 HeLa cells 
expressing SH4-YES-GFP were transfected with mouse-NAE-dsRED 12 hours before transfection with a 
siRNA against human NAE1. Post-transfection 36 hours, live-cell confocal microscopy was applied for the 
analysis of subcellular localization of the SH4 fusion protein. 
 
 
As shown in Figure 35 intracellular accumulation of SH4-YES-GFP caused by silencing 
of NAE1 is prevented after the cells were transiently transfected with mouse homolog 
NAE1 dsRED. Non-transfected cells however still show a pronounced intracellular 
retention of SH4-YES-GFP. These results excluded the possibility of mistargeting of 
siNRA against NAE1 and thus indicated the requirement of NAE1 in correct targeting of 
SH4-YES to the plasma membrane. One challenge was the transient transfection 
efficiency. After optimization of the protocol, the transfection efficiency was low. We 
performed rescue experiments for other gene products involved in the neddylation 
pathway as well; however, we were not able to transfect the cells successfully with 
respective mouse or rat homolog constructs.  
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3.6 INVESTIGATION	  OF	  A	  POTENTIAL	  ROLE	  OF	  NEDDYLATION	  IN	  
SH4-­‐DEPENDENT	  PROTEIN	  TARGETING	  	  
 
Since knockdown of APP did not result in a pronounced intracellular retention of both 
SH4-proteins, we decided to focus our study on whether NAE1 as a component of 
neddylation or a functional neddylation pathway plays a role in the plasma-membrane 
targeting of SH4-YES. Neddylation, similar to ubiquitination, involves a three-step 
cascade to modify target proteins with ubiquitin-like protein NEDD8. In the first step, a 
NEDD8-specific E1-like enzyme, which is a NAE1/UBA3 heterodimer, activates 
NEDD8 by adenylating the carboxyl terminal glycine residue of NEDD8 followed by 
formation of high-energy thioester bond with a catalytic cysteine residue in UBA3. In the 
next step, NEDD8 is transferred from NAE1/UBA3 to the catalytic cysteine residue of 
the NEDD8-specific E2 enzyme UBC12 by formation of a thioester linkage. In the final 
step, active NEDD8 is subsequently transferred and conjugated to the substrates with the 
help of E3 ligases (Gong and Yeh, 1999).  
3.6.1 Phenotype	  analysis	  under	  knockdown	  conditions	  of	  UBA3	  and	  UBC12	  
 
To analyze the role of neddylation in intracellular targeting of SH4 proteins, we first used 
siRNAs directed against two other components UBA3 and UBC12 involved in the 
neddylation cascade pathway; further we applied dominant-negative mutants of such 
components and finally a pharmacological inhibitor against NAE1.  
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Figure 36 Wide field images of HeLa cells expressing SH4-HASPB-GFP and SH4-YES-mCherry 
treated with siRNAs against UBA3 and UBC12. HeLa cells expressing SH4-HASPB-GFP and SH4-
YES-mCherry were transfected with siRNAs against UBA3 (d-f) and UBC12 (g-i) and subjected to live-
cell wide field microscopy to determine the localization of both SH4 fusion proteins.  
 
Figure 36 shows wide field microscopy images of HeLa cells expressing SH4-HASPB-
GFP and SH4-YES-mCherry, which were transfected by respective siRNAs against 
UBA3 and UBC12 for 36 hours before protein expression was induced for additional 12 
hours. siRNA treatments against UBA3 and UBC12 caused perinuclear accumulation of 
SH4-proteins.  
3.6.2 Determination	  of	  knockdown	  efficiencies	  of	  UBA3	  and	  UBC12	  on	  mRNA	  
level	  	  
 
As mentioned in the previous section, we employed siRNA mediated knockdown against 
UBA3 and UBC12 to study the intracellular localization of SH4-proteins. Each siRNA 
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was transfected for 48 hours followed by analysis of UBA3 and UBC12 on mRNA level 
by RT-qPCR. 
 
Figure 37 Determination of knockdown efficiencies of UBA3 and UBC12 on mRNA levels by RT-
qPCR. The mRNA levels of UBA3 and UBC12 were quantified by Realtime-qPCR in HeLa cells 
expressing SH4-HASPB-GFP and SH4-YES-mCherry. Graphs indicate relative mRNA levels after 48h in 
cells treated with respective siRNAs. 
 
Figure 37 shows that around 30% of UBA3 and 27% of UBC12 on mRNA levels 
remained in the cells expressing SH4-HASPB-GFP and SH4-YES-mCherry 48 hours 
after knockdown with siRNAs directed against UBA3 and UBC12, respectively.  
 
3.6.3 	  Analysis	  of	  wide	  field	  microscopy	  data	  with	  automated	  image	  analysis	  
tool	  
 
Respective siRNAs were immobilized on 384-well plates and subsequently cell lines 
expressing SH4-HASPG-GFP and SH4-YES-mCherry were cultured on siRNA arrays to 
be reverse transfected by respective siRNAs. We imaged the cells at two different time-
points, 48h and 72 hours, post siRNA transfection. With the automatic software analysis 
tool, we determined the percentage of cells displaying hits on each position and 
determined hit scores using the standard deviation and also the median of the incidence 
rate of each hit phenotype of all 384 spots on the plate.  
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Figure 38 Hit scores of siRNA treatments against COPB, PHF5A, UBA3 and UBC12 by an 
automated image analysis tool. 48 hours after transfection with scrambled siRNA and respective siRNAs 
against COPB, PHF5A, UBA3 and UBC12, live-cell wide-field microscopy data were analyzed by an 
automated image analysis tool to determine the hit scores. The green line indicates the average score of 
treatment with scrambled siRNA in SH4-HASPB-GFP. The red line indicates the average score of 
treatment with scrambled siRNA in SH4-YES-mCherry. 
 
Figure 38 shows an automated image analysis result of HeLa cells expressing SH4-
HASPB-GFP and SH4-YES-mCherry after respective RNAi treatments 48 hours post 
transfection. Hit scores of knockdown UBA3 and UBC12 are higher than the negative 
control, however much lower than the hit scores of the positive controls by using siRNAs 
against COPB and PHF5A in both SH4-reporter proteins. 
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Figure 39 Hit scores of siRNA treatments against COPB, PHF5A, UBA3 and UBC12 by an 
automated image analysis tool. 72 hours after transfection with scrambled siRNA and respective siRNAs 
against COPB, PHF5A, UBA3 and UBC12, live-cell wide-field microscopy data were analyzed by an 
automated image analysis tool to determine the hit scores. The green line indicates the average score of 
treatment with scrambled siRNA in SH4-HASPB-GFP. The red line indicates the average score of 
treatment with scrambled siRNA in SH4-YES-mCherry. 
 
Figure 39 shows an automated image analysis result of HeLa cells expressing SH4-
HASPB-GFP and SH4-YES-mCherry after respective RNAi treatments 72 hours post 
transfection. siRNA treatment against UBC12 causes high scores in both SH4-reporter 
proteins and remarkably the highest score in SH4-YES-mCherry comparing to the 
positive controls COPB and PHF5A. Similar results were gained when we down-
regulated NAE1 and NEDD8 in HeLa cells expressing SH4-HASPB-GFP and SH4-YES-
mcherry (Figure 30; Figure 31). It seems that knockdown of NAE1, NEDD8 and UBC12 
affect more the intracellular targeting of SH4-YES than SH4-GFP to the plasma 
membrane.  
Knockdown of UBA3 also causes relative high scores in both SH4-reporter proteins 
compared to the scores of treatment with scrambled siRNAs, however lower than positive 
controls caused by siRNA treatments against PHF5A and COPB1. Scores of positive 
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controls gained in this experiment are general low due to the fact that cells might undergo 
apoptosis with the extended knockdown time for 72 hours.  
 
Overall, knockdown of UBA3 and UBC12 did not cause intracellular retention of any 
SH4-reporter proteins after 48 hours; however, at the extended time of 72 hours, UBA3 
and UBC12 caused comparable scores to the positive controls in both SH4-reporter 
proteins. We observed that 48 hours after siRNA transfection effects mildly on the 
localization of SH4 proteins, while extended knockdown period of 72 hours resulted a 
significant intracellular retention of both SH4-reporter proteins. These results suggest a 
requirement of UBA3 and UBC12 in the intracellular transport of SH4-reporter proteins 
and could further indicate a requirement for a functional neddylation pathway.  
 
Taken together all the microscopy data under respective knockdown conditions and the 
results by applying automated analysis tool, we could conclude that:  
1) Knockdown of NAE1 caused intracellular retention of SH4-YES with a time 
period of 48 hours post transfection. 
2) Knockdown of NEDD8, UBA3 and UBC12 caused intracellular retention of both 
SH4-reporter proteins with an extended time period of 72 hours post transfection. 
3) APP is probably not involved in the trafficking of both SH4-proteins to the 
plasma membrane. 
In addition, we were able to confirm that the intracellular accumulation of SH4-YES was 
indeed caused by RNAi-mediated down-regulation of NAE1 by the rescue experiment. 
 
3.6.4 Inhibition	  of	  neddylation	  pathway	  by	  using	  dominate	  negative	  constructs	  
 
We focused our study on the question whether a dysfunctional neddylation pathway 
affects on the localization of the acylated reporter proteins especially on SH4-YES. As a 
second independent approach, we used dominant-negative mutants of components 
involved in neddylation to inhibit the pathway. NAE1 443-479, first described in (Chen 
et al., 2000), is a 36-amino acid fragment of NAE1 to which UBA3 binds. With this 
construct, the function of endogenous NAE1 is supposed to be inhibited due to the 
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competition of NAE1 443-479 for binding to UBA3. UBC12C111S, in which the 
NEDD8 E2 active site a single cysteine is mutated to serine (Wada et al., 2000) binds 
NEDD8 covalently, forming a covalent oxyester bond with the free carboxyl group of the 
C-terminal glycine of NEDD8 that is stable and blocking the transfer of NEDD8 onto the 
substrate (Leck et al., 2010). Similar to UBC12C111S, UBA3C216S is supposed to bind 
NEDD8 and thus block the neddylation pathway in similar manner. We also designed 
construct NEDD8ΔGG, a conjugative-defective protein, which is supposed to compete 
against cellular NEDD8 and thus could be able to block the neddylation pathway. 
 
3.6.5 Phenotype	  analysis	  by	  using	  dominant	  negative	  constructs	  	  
 
We transiently transfected the dominant negative constructs in pIRES vector containing 
dsRED in the second open reading frame in HeLa cells expressing SH4-YES-GFP and 
subsequently, subjected the cells to confocal microscopy for the determination of the 
subcellular localization of SH4-YES-GFP. 
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Figure 40 Confocal microscopy analysis of HeLa cells expressing SH4-YES-GFP after transient 
transfection of dominant negative constructs. HeLa cells were transient transfected with respective 
dominant negative constructs before SH4-YES-GFP expression was induced by cultivation in the presence 
of doxycycline for additional 12 hours. UBC12 (a-c), UBC12C111S (g-i), UBA3C216S (j-l), NAE1 443-
479 (j-l), NEDD8ΔGG (m-o). 
 
Wild-type UBC12 was used as a negative control while other 4 dominant negative 
constructs UBC12C111S, UBA3C216S and NAE1 443-479 as well as NEDD8ΔGG were 
used to block the neddylation pathway at different steps. Transfected cells were in red 
due to the overexpression of dsRED (Figure 40). A challenge for the experiment was the 
transient transfection efficiency. After optimization of transfection conditions, we were 
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able to transfect the cells with UBC12C111S with a transfection efficiency around 50% 
of the whole cell population, while transfection efficiencies of the other three DN 
constructs were below 15% of cell population. Compared to non-transfected cells, the 
overexpression of UBC12C111S or UBA3C216S as well as NAE1 443-479 and 
NEDDΔGG did not cause a significant intracellular accumulation of SH4-YES-GFP as 
shown in Figure 40.  
3.6.6 Neddylation	  blocking	  assay	  after	  transfection	  of	  respective	  dominant	  
negative	  constructs	  
 
We performed a neddylation-blocking assay to verify blocking efficiencies after transient 
transfection of respective dominant-negative constructs as described in Soucy et al., 
2009. 
   
Figure 41 Determination the blocking efficiency of dominant negative constructs on cellular 
neddylation. HeLa cells expressing SH4-YES-GFP were transfected with respective dominant negative 
constructs UBC12C111S, UBA3C216S, NEDD8ΔGG and NAE1 443-479. UBC12 was used as a negative 
control. Cell lysates were collected and analyzed by Western blotting with anti NEDD8 and GPADH 
antibodies.  
 
HeLa cells were harvested 20h post transiently transfection. Cellular levels of neddylated 
cullins were detected by using anti-NEDD8 antibody in Western Blot (Figure 41). 
Neddylated UBC12C111S (32kD) and UBA3C216S (62kD) were detected by anti-
NEDD8 antibody as well. Protein amounts were normalized to GAPDH.  
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Figure 42 Quantification on protein level of neddylation blocking assay. HeLa cells expressing SH4-
YES-GFP were transfected with respective dominant negative constructs. Neddylated cullins were detected 
using an anti-NEDD8 antibody. Signals were quantified by using a Odyssey imaging system  
 
Figure 42 shows a quantification of the inhibition efficiencies of respective dominant 
negative constructs on neddylation. The inhibition efficiency on the formation of cullin-
NEDD8 by the overexpression of dominant negative construct UBC12 C111S is around 
50% and the corresponding transfection efficiency was around 60%, indicating a high 
inhibition efficiency in transfected cells. Similar to UBC12C111S, overexpression of the 
dominant negative constructs UBA3C216S, NEDD8ΔGG and NAE1 443-479 inhibited 
the neddylation of cullins at 25%, 10% and 10% corresponding the transfection 
efficiencies of around 15%, respectively. These results suggested the dominant negative 
construct UBC12C111S indeed blocked the neddylation pathway in the transfected cells. 
However, it is difficult to draw a conclusion about the other dominant negative constructs 
due to the low transfection efficiencies. 
 
3.6.7 Inhibition	  of	  NAE1	  with	  a	  pharmacological	  inhibitor	  MLN4924	  
 
Another way to probe the activity of an enzyme is to use pharmacological compounds 
with defined biochemical activities. To determine if neddylation is required for the 
correct targeting of SH4-proteins to the plasma membrane, we used MLN4924 as an 
inhibitor for NAE1, which is structurally related to adenosine 5´monophosphate (AMP)- 
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a tight binding product of the NAE reaction (Soucy et al., 2009). MLN4924 is reported 
and well characterized as a selective NAE1 inhibitor, which inhibits only NAE1 without 
affecting the function of ubiquitin-activating enzyme (UAE) and SUMO-activating 
enzyme (SAE).  
 
Figure 43 Confocal microscopy analysis of HeLa cells expressing SH4-YES-GFP treated with DMSO 
and MLN4924. HeLa cells expressing SH4-YES-GFP were subjected to mock with 1% DMSO (a) or 1 
µM inhibitor MLN4924 for 6 hours (b). 
 
HeLa cells expressing SH4-YES-GFP were treated with 1% DMSO as mock control and 
1 µM MLN4924 for 6 hours. Subsequently, treated cells were subjected to confocal 
microscopy analysis. Figure 43 shows that the treatment with MLN4924 resulted in a 
mild intracellular retention of SH4-YES-GFP. In order to prove that cellular neddylation 
is indeed blocked by MLN4924, we performed the same neddylation blocking assay as 
for the transient transfection of dominant negative constructs. 
 
 
 
Figure 44 Determination the blocking efficiency of MLN4924 on cellular neddylation. HeLa cells 
expressing SH4-YES-GFP were incubated with 1% DMSO or 1 µM MLN4924 for 6 hours. Cell lysates 
were collected and analyzed by Western blotting with NEDD8 and GPADH antibodies. 
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HeLa cells expressing SH4-YES-GFP were incubated with 1 µM MLN4924 for 6 hours. 
Cell lysate were analyzed for the inhibition efficiency of MLN4924 on the formation of 
NEDD8-cullin conjugates by using an antibody against NEDD8 on Western Blot (Figure 
44). Normalized to GAPDH protein level, about 13% of NEDD8-cullin remained in the 
cells after 6-hour incubation with MLN4924. These results suggest that neddylation was 
indeed blocked by MLN4924 at the time point for the confocal microscopy analysis; 
however, the blocking of neddylation solely resulted in a mild intracellular retention of 
SH4-YES-GFP.  
3.6.8 Quantification	  of	  intracellular	  accumulation	  of	  SH4	  proteins	  
 
A crucial step of microscopy image analysis is the segmentation of cells and 
classification of hit phenotypes. With the automated image analysis tool developed by S. 
Remmele used for the previous study so far, we are able to identify phenotypes with 
regard to the localization of SH4-reporter proteins. This tool represents a fast, reliable 
and unbiased system, especially suitable for high-content screening. However, a 
quantification of the intracellular retention of SH4- reporter proteins within one cell is not 
possible. Another limitation is that the software is solely able to quantify pictures taken 
by wide field microscopy at 10X magnification. A further challenge is to quantify 
phenotypes in a heterogeneous system, quite often e.g. when the transfection efficiency 
of the cells is not 100%. In this case, the automated image analysis tool failed to 
discriminate the untransfected cells. To overcome these limitations, we therefore 
established single cell assay by using of ImageJ as a quantification tool. 
Previous studies showed that Bodipy-Cer are internalized and then localize mainly in the 
trans-Golgi and trans-Golgi network (Ladinsky et al., 1994). We used of Bodipy-Cer to 
identify the perinuclear area containing potential accumulation sites for SH4-reporter 
proteins. Further, we quantified the intracellular accumulation of SH4-reporter protein 
per cell. As described, Z-stacks of cells were taken under identical parameters and 
exposure time. Only the stacks containing potential accumulation sites for SH4-reporter 
proteins, which are marked by Bodipy-Cer in red, are considered for the calculation 
afterwards. For each stack, the intracellular accumulation site of SH4-reporter proteins 
was defined as Area of Interest (AOI). Integrated intensity of AOI and total signal of each 
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slice was then measured using ImageJ. Afterwards, both values were summed up 
respectively and the percent of intracellular accumulation of SH4-reporter protein was 
calculated by the value of AOI divided by the total signal value. 
 
Figure 45 Confocal microscopy analysis of HeLa cells expressing SH4-YES-GFP after mock 
treatment and treatments with MLN4924 and 2-BP. HeLa cells expressing SH4-YES-GFP were 
incubated with MLN4924 for 6 hours. Bodipy Cer-Tx was applied directly into the medium. Subsequently, 
cells were stored at 4°C for 1 hour (2 hours after adding MLN4924) and further 3 hours incubation at 37°C. 
Mock treatment (a-c), MLN4924 treatment (d-f), 2-bromopalmitat treatment (2-BP) (g-i). 
 
Figure 45 shows confocal microscopy images of HeLa cells expressing SH4-YES-GFP 
after treatment treated with 1% DMSO, 3 µM MLN4924 and 100 µM 2-bromopalmitat 
for 6 hours after protein expression was induced by adding doxycycline for 12 hours. The 
fifth layer of z-stacks is depicted where the area containing the potential accumulation 
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site for SH4-reporter proteins is red, marked by Bodipy Cer-TxRED (Invitrogen). A 
moderate intracellular accumulation of SH4-YES-GFP is observed after treatments with 
MLN4924 as well as 2-bromopalmitat as a positive control. 
 
 
Figure 46 Quantification of intracellular accumulation of SH4-YES-GFP after respective treatments 
by using two-tailed unpaired student-t-test. HeLa cells expressing SH4-YES-GFP was treated with 1% 
DMSO, 3µM of MLN4924 for 6 hours and 100 µM of 2-BP for 24 hours. 
 
As described in the previous paragraph, the obtained values of each treatment are 
presented in Figure 46. The difference between mock and MLN4924 or mock and 2-BP 
treatment is 3%, respectively, which are relative low however statistically significant by 
using two-tailed unpaired student´s t-test. These results indicate that the correct targeting 
of SH4-YES-GFP is affected by the treatment of MLN4924, suggesting a requirement of 
NAE1, which is in accordance with the results of studies by applying RNAi and 
dominant negative constructs as methods.   
Although data from RNAi showed that downregulation of molecular components 
involved in neddylation pathway affected the intracellular transport of SH4-YES, 
experiments by using dominant negative construct UBC12C111S and NAE1 inhibitor 
MLN4924 demonstrated a relative moderate effect on the targeting of SH4-YES. We 
might conclude that the neddylation is required however not essential for correct 
targeting of SH4-YES.   
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4 Discussion	  
 
4.1 CLASSIFICATION	  OF	  GENE	  PRODUCTS	  IDENTIFIED	  IN	  MANUAL	  
VALIDATION	  APPROACH	  
 
A genome-wide microscopy-based RNAi screen was carried out to identify cellular 
components involved in intracellular targeting of SH4-domain-containing proteins in a 
previous study. Generated microscopy data were analyzed by applying a software-based 
image analysis module, which can detect and quantify intracellular retention of SH4 
fusion proteins. All together 286 genes were identified in the primary screen by 
application of suitable score thresholds. These 286 genes were further validated by 
automated and 12 genes were validated by manual screening approaches in the current 
study. We used two independent siRNAs targeting different regions of each mRNA and 
subjected doxycycline-inducible HeLa cells expressing SH4-HASPB-GFP and SH4-
YES-mCherry directly to wide field microscopy. With a manual microscopy-based 
approach, we were able to image the cells at two different time-points, 48 hours and 60 
hours post siRNA transfection. The manual microscopy-based approach reduced 
screening time which is an advantage compared to the complete validation screen of 286 
gene products by using automated microscopy carried out in parallel. We validated and 
identified 5 gene products by manual inspection: NAE1, PHF5A, CCDC43 and 
GALTNL4 as well as MAK10 in manual validation approach. Stable HeLa cells 
expressing SH4-HASPB-GFP and SH4-YES-mCherry showed a pronounced intracellular 
accumulation of SH4-proteins after respective siRNA treatments.  
 
4.1.1 Potential	  roles	  of	  PHF5A,	  GALTNL4	  and	  MAK10	  in	  SH4-­‐domain-­‐
dependent	  protein	  transport	  
 
PHD finger protein 5A was a gene product identified in the manual microscopy-based 
validation approach. Microscopy analysis showed a pronounced intracellular retention of 
SH4 protein after siRNA treatment against PHF5A (Figure 12). PHF5A is a small nuclear 
protein containing a PHD domain, a subunit of the splicing factor 3b protein complex and 
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may act as a chromatin-associated protein. Most possibly, knockdown of PHF5A may 
affect indirectly the intracellular transport of SH4-proteins to the plasma membrane.  
 
One gene product identified in the manual microsocopy-based approach was putative 
polypeptide N-acetylgalactosaminyltransferase-like protein 4 (GALNTL4) (Figure 13), 
which is an integral membrane protein and localizes to Golgi apparatus. According to 
sequence homology analysis, GALNTL4 may catalyze the initial reaction in O-linked 
oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a 
serine or threonine residue on target proteins. Previous studies showed that both N- and 
O-glycosylation are critically important in the sorting of some membrane glycoproteins 
(Gut et al., 1998; Scheiffele et al., 1995; Spodsberg et al., 2001; Yeaman et al., 1997). 
siRNA mediated knockdown of GALNTL4 might abolish the glycosylation of membrane 
glycoproteins that are involved in the formation or stabilization of lipid rafts clusters at 
the Golgi apparatus, which is hypothesized as a prerequisite for the targeting of SH4 
proteins to the plasma membrane, thus might affect the plasma-membrane targeting of 
SH4 proteins.  
 
siRNA treatment against N-alpha-acetyltransferase 35, NatC auxiliary subunit (MAK10 
homolog) results a pronounced intracellular retention of both SH4-proteins (Figure 14). 
Studies in yeast showed that MAK10 functions as a component of the N-terminal 
acetyltransferase C (NatC) complex catalyzing acetylation of N-terminal methionine 
residues. Recent work has suggested that acetylation of α-tubulin on lysine 40 is common 
and can be found on stable microtubules in most cell types (Hammond et al., 2008). 
Further, it was postulated that kinesin-1 has higher affinity to acetylated microtubulin in 
vitro and pharmacological treatments that increase microtubule acetylation cause a 
misdirection of kinesin-1 transport of its cargo to nearly all neurite tips in vivo (Reed et 
al., 2006). In addition, it was also shown that α-tubulin plays a positive role in motor-
based trafficking in mammals (Janke et al., 2005; Reed et al., 2006; van Dijk et al., 
2007). By using Mass spectrometry as a tool, cytoskeletal proteins are identified in the 
samples associated with SH4-HASPB-and SH4-YES-containing DRM fractions 
(unpublished data, Paulina Turcza, Nickel lab). Therefore, it might be that the trafficking 
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of SH4-proteins to the plasma membrane requires acetylated microtubules for the 
transport from TGN to the plasma membrane.  
 
Since PHF5A is located in the nucleus and our limited knowledge on the putative 
functions of GALNTL4, MAK10 homolog and CCDC43, whose functions are unknown, 
we focused our study on the role of NAE1 and a potential requirement of the neddylation 
pathway in the intracellular targeting of SH4 proteins to the plasma membrane (discussed 
in the section 4.3).  
 
4.2 CLASSIFICATION	  OF	  GENE	  PRODUCTS	  IDENTIFIED	  IN	  
AUTOMATED	  VALIDATION	  APPROACH	  
 
286 hits identified during primary screening were validated by using automated 
microscopy platform in parallel to the manual validation approach. The list of validated 
gene products whose down-regulation causes intracellular retention of SH4 reporter 
molecules consists of 54 gene products. We validated the involvements and further 
characterized the involvement of 1) coatomer since several subunits like COPB1 and 
COPA were also validated in the automated microscopy-based screen; 2) MVD which is 
involved in the lipid metabolism; and 3) PKCα since reversible phosphorylation as a 
molecular switch regulates the plasma membrane targeting of SH4 proteins (Tournaviti et 
al., 2009). 
 
4.2.1 Coatomer	  as	  a	  component	  of	  SH4-­‐domain-­‐dependent	  protein	  transport	  
 
COPB1 was the first gene product identified in the genome-wide RNAi screen to play a 
role in Sh4-domain-dependent protein transport. Microscopy analysis showed that 
downregulation of COPB1 caused a pronounced intracellular accumulation of SH4-
domain proteins. Further, we also observed a similar effect after knock down of COPD, 
another subunit of heptameric coatomer complex (Figure 16). Analysis of knockdown 
efficiencies on the protein level showed that down-regulation of the coatomer subunit 
COPB1 resulted in decreased protein levels of other coatomer subunits such as COPD 
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and vice versa (Figure 17). This indicated that downregulation of one coatomer subunit 
probably resulted in destabilization of the heterooligomeric coatomer complex. Coatomer 
as the coat protein of COPI transport vesicles mediates retrograde transport from the 
Golgi to the ER and also bidirectional traffic between Golgi cisternae (Rothman, 1996). 
Using immuno-electron microscopy, it has been shown that coatomer not only localizes 
to the intermediate compartment and the Golgi, but also associates with membranes of 
the trans-Golgi-network (Griffiths et al., 1995). Moreover, in vitro generation of TGN-
derived vesicles is dependent on Arf and PKC activity (Simon et al., 1996), two 
components involved in membrane recruitment of coatomer (De Matteis et al., 1993). 
The in vitro generated vesicles had a size of 50-80nm and, in the presence of GTPγS, 
retained a proteinaceous coat (Simon et al., 1996). Additionally, it was shown that 
coatomer was required for and present on in vitro generated TGN-derived vesicles 
(Simon et al., 1998). These data may suggest a role of coatomer in the formation of TGN-
derived vesicles, which may play a role in SH4-dependent proteins transport to the 
plasma membrane. However, in vitro vesicle generation was significantly reduced by 
treatment with BFA (Simon et al., 1996), while transport of SH4-proteins to the plasma 
membrane appears to be BFA-insensitive (Paulina Turcza, unpublished results from our 
laboratory). Whether BFA-insensitive Arf guanine nucleotide exchange factors may play 
a role in this process remains a subject of further investigation in our laboratory. 
Another explanation for our observation might be that downregulation of coatomer 
inhibits indirectly palmitoylation and thus perturbs the insertion of SH4-proteins into 
membrane microdomain. As a consequence, transport from Golgi to the cell surface 
could be blocked because the partitioning into membrane microdomains is hypothesized 
to play a role in further transport to the plasma membrane (Brown and London, 1998; 
Edidin, 2003; Linder and Deschenes, 2007; Smotrys and Linder, 2004; Webb et al., 
2000). Although palmitoylation activity was assigned to several membrane compartments 
and DHHC palmitoyltransferasese associate with ER, Golgi and plasma membrane 
(Greaves et al., 2010; Ohno et al., 2006). Independent analyses of DHHC substrate pairs 
returned a high percentage of DHHC proteins located at Golgi as positive hits 
(Fernandez-Hernando et al., 2006; Fukata et al., 2004; Greaves et al., 2010; Greaves et 
al., 2008; Huang et al., 2004b; Tsutsumi et al., 2009) indicating that palmitoylation 
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occurs at the Golgi apparatus. Recently, Rocks et al., (2010) also stated that 
palmitoylation is detectable only on the Golgi apparatus. Taken together, whether 
coatomer is directly involved in formation of TGN-derived vesicles containing SH4 
proteins or indirectly affects palmitoylation of SH4-domain at the Golgi apparatus 
requires further studies.  
To further exclude off-target effects, we performed rescue experiments by microinjection 
of cells with recombinant coatomer. In previously microinjected cells, down-regulation of 
endogenous coatomer by RNAi did not cause intracellular accumulation of SH4-proteins 
any further (Figure 18). Therefore, using our experimental system, we were able to 
identify COPB1 and COPD as components of a multi-protein complex coatomer, which 
is required for the correct targeting of SH4 dependent protein to the plasma membrane.  
4.2.2 PKCα	  as	  a	  component	  of	  SH4-­‐domain-­‐dependent	  protein	  transport	  
 
Another protein whose down-regulation caused a pronounced intracellular retention of 
SH4 dependent protein transport was a protein kinase C, alpha (PKCα) (Figure 19). 
Members of protein kinase C (PKC) family are serine/threonine kinases that play key 
regulatory roles in a multitude of cellular processes ranging from control of fundamental 
cell autonomous activities, such as proliferation to other cellular functions like memory 
(Mellor and Parker, 1998). PKCα is ubiquitously expressed and activated by stimuli such 
as tyrosine kinase receptors and also physical stresses like hypoxia and mechanical strain 
(Nakashima, 2002). Upon stimulation, PKCα redistributes from cytosol to the entire 
membrane in response to non-specific activator for PKCs such as phorbol myristate 
acetate (PMA). As shown in Figure 20, the reduction of PKCα protein levels to about 
20% compared to the treatment with a scrambled siRNA caused significant perinuclear 
accumulation of SH4 fusion proteins. Further, to test whether PKC activity is required for 
the correct targeting of SH4-proteins, we applied a pharmacological inhibitor of protein 
kinase C to the cells and observed similar intracellular retention of SH4-proteins 
compared to the cells treated with the siRNA against PKCα (Figure 22). These results 
indicate a requirement of protein kinase C activity in the targeting of SH4 proteins to the 
plasma membrane. A possible explanation is that the abolishment of the phosphorylation 
caused the intracellular redistribution of SH4-proteins. Whether SH4 proteins are directly 
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or other targets involved in the transport of SH4 proteins are phosphorylated by PKCα is 
still not clear. However, a previous study showed that reversible phosphorylation and 
dephosphorylation of SH4-domains of HASPB and YES plays a role in the subcellular 
localization and further it was postulated that phosphorylation of SH4 proteins caused the 
perinuclear accumulation at Golgi and endosome and the dephosphorylation lead to the 
attachment to the plasma membrane (Tournaviti et al., 2009). Also in another previous 
study, Resh (1999) postulated the two-signal model for membrane binding of 
myristoylated proteins. As an example for this model, the myristoylated SH4 domain of 
Src contains phosphorylation sites by PKCα and the phosphorylation of SH4 domain 
produces a small shift in the distribution of the Src from the plasma membrane to the 
cytosol (Murray et al., 1998). This model and the study (Tournaviti et al., 2009) 
contradict our observation of intracellular retention of SH4 proteins when PKCα is 
downregulated by RNAi. However, translocation of Src from the membrane to the 
cytosol upon phosphorylation has not been consistently demonstrated (Murray et al., 
1998; Walker et al., 1993). Notably, the possibility is not excluded that the PKCα might 
be more indirectly involved in the intracellular transport of acylated proteins. Therefore, 
further studies are required to obtain a precise role of PKCα in SH4 protein transport. 
4.2.3 A	  role	  of	  lipid	  homeostasis	  in	  SH4-­‐dependent	  protein	  transport	  
 
Previous studies postulated that the targeting of SH4-dependent protein transport requires 
cholesterol-dependent lipid rafts (Brown and London, 1998; Edidin, 2003; Linder and 
Deschenes, 2007; Smotrys and Linder, 2004; Webb et al., 2000). We identified and 
validated a gene product mevalonate decarboxylase (MVD) whose siRNA-mediated 
down-regulation caused intracellular retention of SH4 proteins (Figure 23). MVD is a 
cytosolic homodimer and plays a role in early steps of cholesterol biosynthesis where it 
catalyzes the conversion of mevalonate pyrophosphate into isopentenyl pyrophosphate 
(IPP) and dehydrates its substrate under the consumption of ATP (Hogenboom et al., 
2002; Hogenboom et al., 2003; Toth and Huwyler, 1996). Inhibition of cholesterol 
synthesis by downregulation of the enzyme MVD may lead to a reduction of endogenous 
cholesterol and further interfere with the formation of cholesterol-enriched lipid 
microdomains.  
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To get a better understanding on the role of cholesterol of SH4-protein trafficking, we 
treated cells with methyl-β-cyclodextrin (MβCD) in delipidated medium to deplete 
cellular cholesterol. Unlike other cholesterol-binding agents that incorporate into 
membranes, cyclodextrin are strictly surface-acting and selectively extract membrane 
cholesterol by including it in a central, non-polar cavity of cyclic oligomers of 
glucopyranoside in α-1,4 glycosidic linkage (Pitha et al., 1988). β-cyclodextrins have 
been shown to be a specific cholesterol-binding agent that neither binds nor inserts into 
the plasma membrane (Ohtani et al., 1989). Later, it was found that cholesterol depletion 
of membranes by MβCD could result in tight packing of sphingolipids chains to form a 
rigid gel-like phase (Ilangumaran and Hoessli, 1998). It was also suggested that MβCD 
preferentially extract cholesterol from outside rather than within the sphingolipid 
microdomain and this partly solubilized GPI-anchored and transmembrane proteins from 
microdomains and releases microdomains in both vesicular and non-vesicular form 
(Ilangumaran and Hoessli, 1998).  
 
Remarkably, a pronounced intracellular retention of SH4-proteins was observed after 
one-hour incubation with MβCD (Figure 26). If cholesterol is indeed required for the 
correct targeting of SH4-proteins to the plasma membrane, then addition of exogenous 
cholesterol to the delipidated media should be able to rescue the phenotype caused by 
cholesterol depletion. We indeed observed a pronounced re-localization of SH4-proteins 
to the plasma membrane (Figure 26).  
 
Meanwhile, we measured the cellular cholesterol levels by using nano-elecrospray 
ionization mass spectrometry using phosphatidylcholine (PC) as a bulk lipid to normalize 
data. Compared to treatments with siRNAs against MVD and MβCD, we found a 
reduction of cellular cholesterol concomitantly by 30% and 50% relative to PC, 
respectively (Figure 27). Previous study showed that a reduction of cholesterol levels by 
30-50% affected cholesterol-dependent processes such as shedding of the type XIII 
collagen ectodomain (Vaisanen et al., 2006). To test whether stress potentially exerted by 
MβCD causes a pleiotropic effect on the targeting of SH4 proteins to the plasma 
membrane, we treated cells with ouabain, an unrelated Na+/K+ ATPase inhibitor. We 
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observed a mild effect on overall cell morphology by incubation of ouabain however it 
did not result in perinuclear accumulation of SH4 proteins (Figure 26). Our results 
indicate that interference with cellular cholesterol levels causes a significant intracellular 
retention of SH4-proteins and further corroborate the role of cholesterol-dependent lipid 
rafts in the targeting of SH4 proteins to plasma membrane. They are further in 
accordance with other study suggesting that RNAi-mediated down-regulation of MVD 
affects cholesterol-dependent processes such as Dengue virus replication (Rothwell et al., 
2009). However, studies also showed that cyclodextrin treatment led to serious side 
effects such as lateral protein immobilization (Kenworthy, 2008). As plasma membranes 
can contain up to 40 mol% cholesterol (Zidovetzki and Levitan, 2007), cholesterol 
depletion can perturb cellular functions: for example the plasma membrane can 
depolarize and Ca2+ can be induced to empty (Pizzo et al., 2002) leading to global 
cellular effects (Simons and Gerl, 2010) and indirectly affect the transport of SH4 
proteins.  
 
4.3 A	  ROLE	  OF	  NAE1	  AS	  A	  COMPONENT	  OF	  NEDDYLATION	  IN	  SH4-­‐
DOMAIN-­‐DEPENDENT	  PROTEIN	  TRANSPORT	  
 
One gene product identified in the manual validation approach was Neddylation-
Activating-Enzyme 1 (NAE1). NAE1 was first identified as a novel binding partner of 
the cytoplasmic domain of amyloid precursor protein (APP) and was thus called as APP 
binding protein 1 (APP-BP1) (Chow et al., 1996). Further, NAE1 is involved in 
activation of the ubiquitin-like protein NEDD8 and participates in the neddylation 
pathway (Gong and Yeh, 1999). Similar to ubiquitination, ATP-dependent NEDD8 
activation is initiated by NEDD8 E1 enzyme NAE1-UBA3, which creates a high-energy 
intermediate. This heterodimer of NAE1 and UBA3 is homologous to the amino- and C-
terminal domains of ubiquitin-activating enzyme, respectively (Liakopoulos et al., 1998; 
Osaka et al., 1998; Walden et al., 2003). siRNA mediated down-regulation of NAE1 
caused a significant intracellular accumulation of SH4-YES (Figure 28). Further, we 
were able to confirm the phenotype was not caused by off-target effects by RNAi but 
indeed by downregulation of NAE1 by the rescue experiment with mouse homolog 
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NAE1. In order to get a better understanding of the requirement of NAE1 in the targeting 
of SH4-proteins to the plasma membrane, we further downregulated NEDD8 and APP, 
which functionally interact with NAE1; finally UBA3 and UBC12, which are involved in 
the neddylation pathway. With extended time period, siRNA mediated downregulation of 
NEDD8, UBA3 and UBC12 but not APP caused intracellular retention of SH4-YES and 
SH4-HASPB (Figure 31; Figure 39). These results indicate that neddylation may be 
required in the correct targeting of SH4 proteins. It might be that factors required for the 
localization of SH4 proteins at the plasma membrane could be regulated by NAE1 or by 
covalent attachment of NEDD8. Neddylation of these factors could be required for 
efficient surface delivery of SH4 proteins or might prevent their reinternalization. 
 
Hence, we further focused our study on the question whether an intact neddylation 
pathway is required for the correct targeting of SH4 proteins to the plasma membrane. As 
a second independent approach we used dominant-negative mutants of components 
involved in neddylation to inhibit the pathway. Dominant negative UBC12C111S binds 
NEDD8 covalently by forming an oxyester bond with the free carboxyl group off the C-
terminal of NEDD8 (Leck et al., 2010). Therefore overexpression of UBC12C11S is able 
to block the transfer of NEDD8 onto the substrates, which was confirmed in the 
neddylation blocking assay (Figure 41; Figure 42). However, a pronounced intracellular 
accumulation of SH4-YES is not observed in the cells transfected by UBC12C111S 
compared to untransfected cells (Figure 40). Finally, we applied a pharmacological 
compound to determine if neddylation is indeed required for the correct targeting of SH4-
proteins to the plasma membrane. MLN4924 was identified as a cell-permeable inhibitor 
targeting the E1 for neddylation (Soucy et al., 2009). Further it was shown that 
MLN4924 effectively inhibits NAE1 activity and as a result inhibits downstream 
activities such as activation of the UBC12 and cullin neddylation (Soucy et al., 2009). 
Our data showed that blocking neddylation by incubation with MLN4924 (Figure 44) 
resulted in a mild intracellular retention of SH4-YES (Figure 43). We quantified the 
intracellular accumulation of SH4-proteins per cell (Figure 46). The difference between 
mock and MLN4924 treatments is minor, however it is comparable to the difference 
between mock and the positive control 2-BP which is a palmitoylation inhibitor (Resh, 
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2006) and 2-BP treated cells showed a pronounced intracellular accumulation of SH4-
proteins (Ritzerfeld et al., 2011). Both values are statistically significant by using two-tail 
unpaired student´s T-test. Whether the redistribution of SH4-proteins from the plasma 
membrane to perinuclear region is a direct effect of the abolishment of cullin neddylation 
is not clear. This abolishment or deficiency of cullin neddylation would ultimately lead to 
the accumulation of cullin-RING ubiquitin ligases (CRLs) substrates that are normally 
targeted for degradation by the 26 S proteasome. This accumulation of CRLs substrates 
might indirectly affect the surface delivery of SH4-proteins and explain their intracellular 
redistribution.  
 
Overall, our data suggest that correct targeting of SH4 proteins to the plasma membrane 
may not essentially require a functional neddylation pathway. NAE1 may affect the 
transport of SH4 proteins in neddylation-independent ways. A recent study showed the 
interaction of APP and NAE1 activated Rab5-dependent endocytosis in a neddylation-
independent manner (Laifenfeld et al., 2007). Hence, NAE1 may have a distinct function 
other than neddylation in the transport of SH4 proteins. However, the precise role of 
NAE1 in the targeting of SH4-proteins to the plasma membrane could not be revealed in 
the course of the this study.  
 
4.4 CONCLUSION	  AND	  FUTURE	  PERSPECTIVES	  
 
In the current study we validated gene products identified during primary screening by 
applying independent siRNAs. We confirmed COPB1 and PRCα as necessary 
components for the correct targeting of SH4 proteins to the plasma membrane. Results 
obtained on MVD and cholesterol corroborates the role of cholesterol-dependent 
membrane microdomains in SH4 proteins trafficking (McCabe and Berthiaume, 1999; 
McCabe and Berthiaume, 2001; Tournaviti et al., 2009; Webb et al., 2000). Another 
observation of this study was the role of NAE1 and neddylation pathway in the targeting 
of SH4 proteins. Our data suggest the correct targeting of SH4 proteins to the plasma 
membrane may not essentially require a functional neddylation pathway, however, down- 
  Discussion 
    
  108 
regulation of NAE1 causes intracellular retention of SH4-YES suggesting additional 
functions of NAE1. 
Further investigations on the lipid and protein composition of SH4 proteins containing 
lipid rafts will help to have a close sight on the putative interacting partners of SH4 
proteins. In addition, a microscopy independent readout of the distribution of SH4 protein 
might help to confirm the intracellular accumulation of SH4 proteins. Recent studies on 
another dually acylated Src-family tyrosine kinase Lyn showed that the requirement of 
the tyrosine-kinase domains but not the kinase activity of Lyn for its biosynthetic 
targeting to caveolin-positive Golgi membrane (Ikeda et al., 2009) and further Nadolski 
and Linder et al., (2009) suggested that an SH4 domain is not sufficient to confer the 
specificity for a DHHC protein. It might be interesting to study the full-length form of 
YES with its kinase domain. Finally, the putative roles of the identified gene products in 
SH4-domain dependent transport will be interesting aspects of future studies. 
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5 Abbreviations	  
 
2-BP   2-bromopalmitate 
APT   acyl protein thioesterase 
ATP   adenosine triphosphate 
ARF   ADP-ribosylation factor 
COPA   alpha-COP 
N-terminal  amino-terminal 
APP   amyloid precursor protein 
APP-BP1  amyloid precursor protein binding protein 1 
CCDC43  coiled-coil domain containing 43 
COPB   beta-COP 
BFA   brefeldin A 
C-terminal  carboxy-terminal 
COP   coat protein 
DNA   desoxyribonucleic acid 
dNTP   desoxyribonucleotid triphosphate 
DRM   detergent-resistant membrane 
dsRNA  double-stranded RNA 
D-MEM  Dulbecco´s modified eagle medium 
ER   endoplasmic reticulum 
ERGIC  ER/Golgi intermediate compartment 
E.coli   Escherichia coli 
FCS   fetal calf serium 
FGF   fibroblast growth factor 
GALNTL4 putative ppolypeptide N-acetylgalactosaminyltransferase-like 
protein 4 
GPI   glycosylphosphatidylinositol 
GPF   green fluorescent protein 
GAP   growth associated protein 
GTP   guanosine triphosphate 
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HSPG   heparin sulfate progeoglycan 
mRNA   messenger RNA 
MAK10  N-alpha-acetyltransferase 35, Natc auxiliary subunit 
MVD   Mevalonate (diphospho) dehydrogenase 
MARCKS  myristoylated alanine-rich C kinase substrate 
NAE1   nedd-activating enzyme1 
NEDD8  neural precursor cell expressed, developmentally downregulated8 
PBS   phosphate buffered saline 
PE   phosphatidylethanolamine 
PI   phosphatidylinositol 
PI(4,5)P2  phsophatidylinositol-4,5-bisphosphate 
PM   plasma membrane 
PCR   polymerase chain reaction 
PAT   protein acyltransferase 
PKC   protein kinase C 
PRKCA  protein kinase C alpha 
PTP   protein tyrosine phosphatase 
RNA   ribonucleic acid 
RNAi    RNA interference 
Rpm   rounds per minute 
siRNA   short interfering RNA 
SRP   signal recognition paticle 
SNARE  SNAP receptor 
SNAP   soluble NSF attachment protein 
TGN   trans-Golgi network 
UBA3   ubiquitin-like modifier activating enzyme 3 
UBC12  ubiquitin-conjugating enzyme E2M 
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